Arturo Casadevall - Publications

Affiliations: 
Yeshiva University, New York, NY, United States 
Area:
Microbiology Biology, Cell Biology, Biomechanics Biophysics

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Crawford CJ, Guazzelli L, McConnell SA, McCabe O, d'Errico C, Greengo SD, Wear MP, Jedlicka AE, Casadevall A, Oscarson S. Synthetic Glycans Reveal Determinants of Antibody Functional Efficacy against a Fungal Pathogen. Acs Infectious Diseases. PMID 37856427 DOI: 10.1021/acsinfecdis.3c00447  0.319
2020 Benner SE, Patel EU, Laeyendecker O, Pekosz A, Littlefield K, Eby Y, Fernandez RE, Miller J, Kirby CS, Keruly M, Klock E, Baker OR, Schmidt HA, Shrestha R, Burgess I, ... ... Casadevall A, et al. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors. The Journal of Infectious Diseases. PMID 32910175 DOI: 10.1093/Infdis/Jiaa581  0.313
2020 Frazão SO, Sousa HR, Silva LGD, Folha JDS, Gorgonha KCM, Oliveira GP, Felipe MSS, Silva-Pereira I, Casadevall A, Nicola AM, Albuquerque P. Laccase Affects the Rate of Cryptococcus neoformans Nonlytic Exocytosis from Macrophages. Mbio. 11. PMID 32900810 DOI: 10.1128/Mbio.02085-20  0.374
2020 Chrissian C, Camacho E, Kelly JE, Wang H, Casadevall A, Stark RE. Solid-state NMR spectroscopy identifies three classes of lipids in melanized cell walls and whole fungal cells. The Journal of Biological Chemistry. PMID 32859751 DOI: 10.1074/Jbc.Ra120.015201  0.332
2020 Casadevall A, Joyner MJ, Pirofski LA. Implications of COVI-19 antibody dynamics for immunity and convalescent plasma therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32805024 DOI: 10.1093/Cid/Ciaa1213  0.301
2020 Pirofski LA, Casadevall A. The state of latency in microbial pathogenesis. The Journal of Clinical Investigation. 130: 4525-4531. PMID 32804154 DOI: 10.1172/Jci136221  0.321
2020 Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, Littlefield K, Kumar S, Naik HM, Betenbaugh M, Shrestha R, Wu AA, Hughes RM, Burgess I, Caturegli P, ... ... Casadevall A, et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. The Journal of Clinical Investigation. PMID 32764200 DOI: 10.1172/Jci142004  0.322
2020 Casadevall A, Joyner MJ, Pirofski LA. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. The Journal of Clinical Investigation. PMID 32634126 DOI: 10.1172/Jci139760  0.328
2020 Kuttel MM, Casadevall A, Oscarson S. Capsular GXM Conformation and Epitope Presentation: A Molecular Modelling Study. Molecules (Basel, Switzerland). 25. PMID 32517333 DOI: 10.3390/Molecules25112651  0.341
2020 Godbout EJ, Madaline T, Casadevall A, Bearman G, Pirofski LA. The damage response framework and infection prevention: From concept to bedside. Infection Control and Hospital Epidemiology. 1-5. PMID 31915082 DOI: 10.1017/Ice.2019.354  0.321
2020 Chrissian C, Camacho E, Fu MS, Prados-Rosales R, Chatterjee S, Cordero RJB, Lodge JK, Casadevall A, Stark RE. Melanin deposition in two species depends on cell-wall composition and flexibility. The Journal of Biological Chemistry. PMID 31896575 DOI: 10.1074/Jbc.Ra119.011949  0.309
2020 Guazzelli L, Crawford CJ, Ulc R, Bowen A, McCabe O, Jedlicka AJ, Wear MP, Casadevall A, Oscarson S. A synthetic glycan array containing Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide fragments allows the mapping of protective epitopes Chemical Science. 11: 9209-9217. DOI: 10.1039/D0Sc01249A  0.349
2019 de Oliveira FFM, Paredes V, de Sousa HR, D'Áurea Moura ÁN, Riasco-Palacios J, Casadevall A, Felipe MSS, Nicola AM. Thioredoxin Reductase 1 Is a Highly Immunogenic Cell Surface Antigen in spp., , and . Frontiers in Microbiology. 10: 2930. PMID 31993026 DOI: 10.3389/Fmicb.2019.02930  0.4
2019 Casadevall A, Fang FC. The intracellular pathogen concept. Molecular Microbiology. PMID 31762116 DOI: 10.1111/Mmi.14421  0.362
2019 Pirofski LA, Casadevall A. Antimicrobial therapy in the context of the Damage-response framework: The prospect of optimizing therapy by reducing host damage. Antimicrobial Agents and Chemotherapy. PMID 31740558 DOI: 10.1128/Aac.01800-19  0.309
2019 Albuquerque P, Nicola AM, Magnabosco DAG, Derengowski LDS, Crisóstomo LS, Xavier LCG, Frazão SO, Guilhelmelli F, de Oliveira MA, Dias JDN, Hurtado FA, Teixeira MM, Guimarães AJ, Paes HC, Bagagli E, ... ... Casadevall A, et al. A hidden battle in the dirt: Soil amoebae interactions with Paracoccidioides spp. Plos Neglected Tropical Diseases. 13: e0007742. PMID 31589617 DOI: 10.1371/Journal.Pntd.0007742  0.302
2019 Hommel B, Sturny-Leclère A, Volant S, Veluppillai N, Duchateau M, Yu CH, Hourdel V, Varet H, Matondo M, Perfect JR, Casadevall A, Dromer F, Alanio A. Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype. Plos Pathogens. 15: e1007945. PMID 31356623 DOI: 10.1371/Journal.Ppat.1007945  0.319
2019 Smith DFQ, Casadevall A. The Role of Melanin in Fungal Pathogenesis for Animal Hosts. Current Topics in Microbiology and Immunology. PMID 31278515 DOI: 10.1007/82_2019_173  0.394
2019 de Souza Gonçalves D, da Silva Ferreira M, Gomes KX, la Noval CR, Liedke S, da Costa GCV, Albuquerque P, Cortines JR, Saramago Peralta RH, Peralta JM, Casadevall A, Guimaraes AJ. Unraveling the interactions of the environmental host Acanthamoeba castellanii with fungi through the recognition by mannose binding proteins. Cellular Microbiology. e13066. PMID 31173452 DOI: 10.1111/Cmi.13066  0.345
2019 Maryam M, Fu MS, Alanio A, Camacho E, Goncalves DS, Faneuff EE, Grossman NT, Casadevall A, Coelho C. The enigmatic role of fungal annexins: the case of Cryptococcus neoformans. Microbiology (Reading, England). PMID 31140968 DOI: 10.1099/Mic.0.000815  0.363
2019 Casadevall A. Global Catastrophic Threats from the Fungal Kingdom : Fungal Catastrophic Threats. Current Topics in Microbiology and Immunology. PMID 31119433 DOI: 10.1007/82_2019_161  0.31
2019 Camacho E, Vij R, Chrissian C, Prados-Rosales R, Gil D, O'Meally RN, Cordero RJB, Cole RN, McCaffery JM, Stark RE, Casadevall A. The structural unit of melanin in the cell wall of the fungal pathogen Cryptococcus neoformans. The Journal of Biological Chemistry. PMID 31118223 DOI: 10.1074/Jbc.Ra119.008684  0.348
2019 Hawk CS, Coelho C, Oliveira DSL, Paredes V, Albuquerque P, Bocca AL, Correa Dos Santos A, Rusakova V, Holemon H, Silva-Pereira I, Felipe MSS, Yagita H, Nicola AM, Casadevall A. Integrin β1 Promotes the Interaction of Murine IgG3 with Effector Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 30894426 DOI: 10.4049/Jimmunol.1701795  0.335
2019 Dragotakes Q, Fu MS, Casadevall A. Dragotcytosis: Elucidation of the Mechanism for Macrophage-to-Macrophage Transfer. Journal of Immunology (Baltimore, Md. : 1950). PMID 30877168 DOI: 10.4049/Jimmunol.1801118  0.322
2019 Casadevall A, Fu MS, Guimaraes AJ, Albuquerque P. The 'Amoeboid Predator-Fungal Animal Virulence' Hypothesis. Journal of Fungi (Basel, Switzerland). 5. PMID 30669554 DOI: 10.3390/Jof5010010  0.348
2019 Nosanchuk JD, Nimrichter L, Casadevall A, Rodrigues ML. A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis. Communicative & Integrative Biology. 1: 37-39. PMID 19169363 DOI: 10.4161/Cib.1.1.6639  0.301
2018 Casadevall A. Melanin triggers antifungal defences. Nature. 555: 319-320. PMID 32094695 DOI: 10.1038/D41586-018-02370-X  0.346
2018 Coelho C, Brown LC, Maryam M, Vij R, Smith DF, Burnet MC, Kyle JE, Heyman HM, Ramirez J, Prados-Rosales R, Lauvau G, Nakayasu ES, Brady NR, Hamacher-Brady A, Coppens I, ... Casadevall A, et al. virulence factors, including Listeriolysin O, are secreted in biologically active Extracellular Vesicles. The Journal of Biological Chemistry. PMID 30504226 DOI: 10.1074/Jbc.Ra118.006472  0.368
2018 Guimarães AJ, de Cerqueira MD, Zamith-Miranda D, Lopez PH, Rodrigues ML, Pontes B, Viana NB, DeLeon-Rodriguez CM, Rossi DCP, Casadevall A, Gomes AMO, Martinez LR, Schnaar RL, Nosanchuk JD, Nimrichter L. Host membrane glycosphingolipids and lipid microdomains facilitate Histoplasma capsulatum internalization by macrophages. Cellular Microbiology. e12976. PMID 30427108 DOI: 10.1111/Cmi.12976  0.558
2018 Chatterjee S, Prados-Rosales R, Tan S, Phan VC, Chrissian C, Itin B, Wang H, Khajo A, Magliozzo RS, Casadevall A, Stark RE. The melanization road more traveled by: precursor substrate effects on melanin synthesis in cell-free and fungal cell systems. The Journal of Biological Chemistry. PMID 30385508 DOI: 10.1074/Jbc.Ra118.005791  0.305
2018 May RC, Casadevall A. In Fungal Intracellular Pathogenesis, Form Determines Fate. Mbio. 9. PMID 30352939 DOI: 10.1128/Mbio.02092-18  0.336
2018 Pirofski LA, Casadevall A. The Damage-Response Framework as a Tool for the Physician-Scientist to Understand the Pathogenesis of Infectious Diseases. The Journal of Infectious Diseases. 218: S7-S11. PMID 30124977 DOI: 10.1093/Infdis/Jiy083  0.311
2018 Rodrigues ML, Casadevall A. A two-way road: novel roles for fungal extracellular vesicles. Molecular Microbiology. PMID 30079549 DOI: 10.1111/Mmi.14095  0.334
2018 Camacho E, Casadevall A. Cryptococcal Traits Mediating Adherence to Biotic and Abiotic Surfaces. Journal of Fungi (Basel, Switzerland). 4. PMID 30060601 DOI: 10.3390/Jof4030088  0.347
2018 Goldman DL, Nieves E, Nakouzi A, Rivera J, Phyu EE, Win TH, Achkar JM, Casadevall A. Serum-Mediated Cleavage of Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase. Msphere. 3. PMID 29950379 DOI: 10.1128/mSphere.00091-18  0.469
2018 Perez-Dulzaides R, Camacho E, Cordero RJB, Casadevall A. Cell-wall dyes interfere with Cryptococcus neoformans melanin deposition. Microbiology (Reading, England). PMID 29939127 DOI: 10.1099/Mic.0.000682  0.331
2018 Fu MS, Coelho C, De Leon-Rodriguez CM, Rossi DCP, Camacho E, Jung EH, Kulkarni M, Casadevall A. Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH. Plos Pathogens. 14: e1007144. PMID 29906292 DOI: 10.1371/Journal.Ppat.1007144  0.378
2018 De Leon-Rodriguez CM, Rossi DCP, Fu MS, Dragotakes Q, Coelho C, Guerrero Ros I, Caballero B, Nolan SJ, Casadevall A. The Outcome of the Macrophage Interaction Depends on Phagolysosomal Membrane Integrity. Journal of Immunology (Baltimore, Md. : 1950). PMID 29858266 DOI: 10.4049/Jimmunol.1700958  0.361
2018 Martinez LR, Boucaud DW, Casadevall A, August A. Factors Contributing to the Success of NIH-Designated Underrepresented Minorities in Academic and Nonacademic Research Positions. Cbe Life Sciences Education. 17: ar32. PMID 29799320 DOI: 10.1187/Cbe.16-09-0287  0.498
2018 Hommel B, Mukaremera L, Cordero RJB, Coelho C, Desjardins CA, Sturny-Leclère A, Janbon G, Perfect JR, Fraser JA, Casadevall A, Cuomo CA, Dromer F, Nielsen K, Alanio A. Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators. Plos Pathogens. 14: e1006982. PMID 29775480 DOI: 10.1371/Journal.Ppat.1006982  0.341
2018 Casadevall A, Coelho C, Alanio A. Mechanisms of -Mediated Host Damage. Frontiers in Immunology. 9: 855. PMID 29760698 DOI: 10.3389/Fimmu.2018.00855  0.344
2018 Freij JB, Fu MS, De Leon Rodriguez CM, Dziedzic A, Jedlicka AE, Dragotakes Q, Rossi DCP, Jung EH, Coelho C, Casadevall A. Conservation of intracellular pathogenic strategy among distantly related Cryptococcal species. Infection and Immunity. PMID 29712729 DOI: 10.1128/Iai.00946-17  0.314
2018 Casadevall A. Antibody-based vaccine strategies against intracellular pathogens. Current Opinion in Immunology. 53: 74-80. PMID 29704764 DOI: 10.1016/J.Coi.2018.04.011  0.365
2018 Nosanchuk JD, Jeyakumar A, Ray A, Revskaya E, Jiang Z, Bryan RA, Allen KJH, Jiao R, Malo ME, Gómez BL, Morgenstern A, Bruchertseifer F, Rickles D, Thornton GB, Bowen A, ... Casadevall A, et al. Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy. Scientific Reports. 8: 5466. PMID 29615812 DOI: 10.1038/S41598-018-23889-Z  0.385
2018 Walker L, Sood P, Lenardon MD, Milne G, Olson J, Jensen G, Wolf J, Casadevall A, Adler-Moore J, Gow NAR. The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles. Mbio. 9. PMID 29437927 DOI: 10.1128/Mbio.02383-17  0.303
2018 Casadevall A, Coelho C, Cordero RJB, Dragotakes Q, Jung E, Vij R, Wear MP. The Capsule of Cryptococcus neoformans. Virulence. 0. PMID 29436899 DOI: 10.1080/21505594.2018.1431087  0.349
2017 Rizzo J, Colombo AC, Zamith-Miranda D, Silva VKA, Allegood JC, Casadevall A, Del Poeta M, Nosanchuk JD, Kronstad JW, Rodrigues ML. The putative flippase Apt1 is required for intracellular membrane architecture and biosynthesis of polysaccharide and lipids in Cryptococcus neoformans. Biochimica Et Biophysica Acta. PMID 29291962 DOI: 10.1016/J.Bbamcr.2017.12.007  0.359
2017 Pirofski LA, Casadevall A. Immune-Mediated Damage Completes the Parabola: Cryptococcus neoformans Pathogenesis Can Reflect the Outcome of a Weak or Strong Immune Response. Mbio. 8. PMID 29233901 DOI: 10.1128/Mbio.02063-17  0.339
2017 Almeida F, Wolf JM, da Silva TA, DeLeon-Rodriguez CM, Rezende CP, Pessoni AM, Fernandes FF, Silva-Rocha R, Martinez R, Rodrigues ML, Roque-Barreira MC, Casadevall A. Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects. Nature Communications. 8: 1968. PMID 29213074 DOI: 10.1038/S41467-017-02126-7  0.403
2017 Fu MS, Casadevall A. Divalent metal cations potentiate the predatory capacity of amoeba for Cryptococcus neoformans. Applied and Environmental Microbiology. PMID 29150507 DOI: 10.1128/Aem.01717-17  0.313
2017 Casadevall A, Pirofski LA. WHAT IS A HOST II: THE ATTRIBUTES OF INDIVIDUAL SUSCEPTIBILITY. Infection and Immunity. PMID 29084893 DOI: 10.1128/Iai.00636-17  0.306
2017 Camacho E, Chrissian C, Cordero RJB, Liporagi-Lopes L, Stark RE, Casadevall A. N-acetylglucosamine affects Cryptococcus neoformans cell-wall composition and melanin architecture. Microbiology (Reading, England). PMID 29043954 DOI: 10.1099/Mic.0.000552  0.343
2017 Nolan SJ, Fu MS, Coppens I, Casadevall A. Lipids affect the Cryptococcus neoformans-macrophage interaction and promote non-lytic exocytosis. Infection and Immunity. PMID 28947642 DOI: 10.1128/Iai.00564-17  0.314
2017 Bowen A, Wear M, Casadevall A. Antibody-mediated Catalysis in Infection and Immunity. Infection and Immunity. PMID 28674034 DOI: 10.1128/Iai.00202-17  0.396
2017 Köhler JR, Hube B, Puccia R, Casadevall A, Perfect JR. Fungi that Infect Humans. Microbiology Spectrum. 5. PMID 28597822 DOI: 10.1128/Microbiolspec.Funk-0014-2016  0.377
2017 Prados-Rosales R, Carreño L, Cheng T, Blanc C, Weinrick B, Malek A, Lowary TL, Baena A, Joe M, Bai Y, Kalscheuer R, Batista-Gonzalez A, Saavedra NA, Sampedro L, Tomás J, ... ... Casadevall A, et al. Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. Plos Pathogens. 13: e1006250. PMID 28278283 DOI: 10.1371/Journal.Ppat.1006250  0.369
2017 Casadevall A. Antibodies to Mycobacterium tuberculosis. The New England Journal of Medicine. 376: 283-285. PMID 28099836 DOI: 10.1056/Nejmcibr1613268  0.324
2016 Grossman NT, Casadevall A. Physiological Differences in C. neoformans in vitro versus in vivo and Their Effects on Antifungal Susceptibility. Antimicrobial Agents and Chemotherapy. PMID 28031206 DOI: 10.1128/Aac.02108-16  0.395
2016 Bowen A, Wear MP, Cordero R, Oscarson S, Casadevall A. A monoclonal antibody to Cryptococcus neoformans glucuronoxylomannan manifests hydrolytic activity for both peptides and polysaccharides. The Journal of Biological Chemistry. PMID 27872188 DOI: 10.1074/Jbc.M116.767582  0.364
2016 da Silva TA, Roque-Barreira MC, Casadevall A, Almeida F. Extracellular vesicles from Paracoccidioides brasiliensis induced M1 polarization in vitro. Scientific Reports. 6: 35867. PMID 27775058 DOI: 10.1038/Srep35867  0.316
2016 Tsukrov D, McFarren A, Morgenstern A, Bruchertseifer F, Dolce E, Gorny MK, Zolla-Pazner S, Berman JW, Schoenbaum E, Zingman BS, Casadevall A, Dadachova E. Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals. Frontiers in Medicine. 3: 41. PMID 27725930 DOI: 10.3389/Fmed.2016.00041  0.327
2016 Casadevall A. To Be or Not Be a (Functional) Antibody Against TB. Cell. 167: 306-307. PMID 27716502 DOI: 10.1016/J.Cell.2016.09.041  0.337
2016 Bowen A, Casadevall A. Revisiting the Immunoglobulin Intramolecular Signaling Hypothesis. Trends in Immunology. PMID 27639628 DOI: 10.1016/J.It.2016.08.014  0.315
2016 McClelland EE, Ramagopal UA, Rivera J, Cox J, Nakouzi A, Prabu MM, Almo SC, Casadevall A. A Small Protein Associated with Fungal Energy Metabolism Affects the Virulence of Cryptococcus neoformans in Mammals. Plos Pathogens. 12: e1005849. PMID 27583447 DOI: 10.1371/Journal.Ppat.1005849  0.567
2016 Stukes S, Coelho C, Rivera J, Jedlicka AE, Hajjar KA, Casadevall A. The Membrane Phospholipid Binding Protein Annexin A2 Promotes Phagocytosis and Nonlytic Exocytosis of Cryptococcus neoformans and Impacts Survival in Fungal Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 27371724 DOI: 10.4049/Jimmunol.1501855  0.811
2016 Casadevall A. Thermal Restriction as an Antimicrobial Function of Fever. Plos Pathogens. 12: e1005577. PMID 27149668 DOI: 10.1371/Journal.Ppat.1005577  0.317
2016 Chen T, Blanc C, Eder AZ, Prados-Rosales R, Souza AC, Kim RS, Glatman-Freedman A, Joe M, Bai Y, Lowary TL, Tanner R, Brennan MJ, Fletcher HA, McShane H, Casadevall A, et al. Association of Human Antibodies to Arabinomannan with Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction. The Journal of Infectious Diseases. PMID 27056953 DOI: 10.1093/Infdis/Jiw141  0.348
2016 DeLeon-Rodriguez CM, Casadevall A. Cryptococcus neoformans: Tripping on Acid in the Phagolysosome. Frontiers in Microbiology. 7: 164. PMID 26925039 DOI: 10.3389/Fmicb.2016.00164  0.356
2016 Cordero RJ, Liedke SC, de S Araújo GR, Martinez LR, Nimrichter L, Frases S, Peralta JM, Casadevall A, Rodrigues ML, Nosanchuk JD, Guimaraes AJ. Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection. Scientific Reports. 6: 21765. PMID 26908077 DOI: 10.1038/Srep21765  0.587
2016 Janda A, Bowen A, Greenspan NS, Casadevall A. Ig Constant Region Effects on Variable Region Structure and Function. Frontiers in Microbiology. 7: 22. PMID 26870003 DOI: 10.3389/Fmicb.2016.00022  0.665
2015 Nosanchuk JD, Stark RE, Casadevall A. Fungal Melanin: What do We Know About Structure? Frontiers in Microbiology. 6: 1463. PMID 26733993 DOI: 10.3389/Fmicb.2015.01463  0.324
2015 Fernandes C, Prados-Rosales R, Silva B, Nakouzi-Naranjo A, Zuzarte M, Chatterjee S, Stark RE, Casadevall A, Gonçalves T. Activation of melanin synthesis in Alternaria infectoria by antifungal drugs. Antimicrobial Agents and Chemotherapy. PMID 26711773 DOI: 10.1128/Aac.02190-15  0.3
2015 Brown L, Wolf JM, Prados-Rosales R, Casadevall A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nature Reviews. Microbiology. 13: 620-30. PMID 26324094 DOI: 10.1038/Nrmicro3480  0.3
2015 García-Rodas R, Trevijano-Contador N, Román E, Janbon G, Moyrand F, Pla J, Casadevall A, Zaragoza O. Role of Cln1 during melanization of Cryptococcus neoformans. Frontiers in Microbiology. 6: 798. PMID 26322026 DOI: 10.3389/Fmicb.2015.00798  0.381
2015 Prados-Rosales R, Toriola S, Nakouzi A, Chatterjee S, Stark R, Gerfen G, Tumpowsky P, Dadachova E, Casadevall A. Structural Characterization of Melanin Pigments from Commercial Preparations of the Edible Mushroom Auricularia auricula. Journal of Agricultural and Food Chemistry. 63: 7326-32. PMID 26244793 DOI: 10.1021/Acs.Jafc.5B02713  0.319
2015 Martinez LR, Casadevall A. Biofilm Formation by Cryptococcus neoformans. Microbiology Spectrum. 3. PMID 26185073 DOI: 10.1128/Microbiolspec.Mb-0006-2014  0.542
2015 Wolf JM, Espadas J, Luque-Garcia J, Reynolds T, Casadevall A. Lipid biosynthetic genes affect Candida albicans extracellular vesicle morphology, cargo, and immunostimulatory properties. Eukaryotic Cell. PMID 26024904 DOI: 10.1128/Ec.00054-15  0.304
2015 Zolla V, Nizamutdinova IT, Scharf B, Clement CC, Maejima D, Akl T, Nagai T, Luciani P, Leroux JC, Halin C, Stukes S, Tiwari S, Casadevall A, Jacobs WR, Entenberg D, et al. Aging-related anatomical and biochemical changes in lymphatic collectors impair lymph transport, fluid homeostasis, and pathogen clearance. Aging Cell. 14: 582-94. PMID 25982749 DOI: 10.1111/Acel.12330  0.766
2015 Casadevall A, Pirofski LA. The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases. Plos Pathogens. 11: e1004717. PMID 25905897 DOI: 10.1371/Journal.Ppat.1004717  0.32
2015 Pirofski LA, Casadevall A. What is infectiveness and how is it involved in infection and immunity? Bmc Immunology. 16: 13. PMID 25887484 DOI: 10.1186/S12865-015-0076-1  0.348
2015 Chatterjee S, Prados-Rosales R, Itin B, Casadevall A, Stark RE. Solid-state NMR Reveals the Carbon-based Molecular Architecture of Cryptococcus neoformans Fungal Eumelanins in the Cell Wall. The Journal of Biological Chemistry. 290: 13779-90. PMID 25825492 DOI: 10.1074/Jbc.M114.618389  0.354
2015 Janda A, Eryilmaz E, Nakouzi A, Pohl MA, Bowen A, Casadevall A. Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences. The Journal of Biological Chemistry. 290: 12090-100. PMID 25778397 DOI: 10.1074/Jbc.M114.618975  0.66
2015 Achkar JM, Chan J, Casadevall A. B cells and antibodies in the defense against Mycobacterium tuberculosis infection. Immunological Reviews. 264: 167-81. PMID 25703559 DOI: 10.1111/Imr.12276  0.384
2015 Majlessi L, Prados-Rosales R, Casadevall A, Brosch R. Release of mycobacterial antigens. Immunological Reviews. 264: 25-45. PMID 25703550 DOI: 10.1111/Imr.12251  0.337
2015 Coelho C, Souza AC, Derengowski Lda S, de Leon-Rodriguez C, Wang B, Leon-Rivera R, Bocca AL, Gonçalves T, Casadevall A. Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans. Journal of Immunology (Baltimore, Md. : 1950). 194: 2345-57. PMID 25646306 DOI: 10.4049/Jimmunol.1402350  0.417
2015 Casadevall A, Pirofski LA. What is a host? Incorporating the microbiota into the damage-response framework. Infection and Immunity. 83: 2-7. PMID 25385796 DOI: 10.1128/Iai.02627-14  0.328
2015 Köhler JR, Casadevall A, Perfect J. The spectrum of fungi that infects humans. Cold Spring Harbor Perspectives in Medicine. 5: a019273. PMID 25367975 DOI: 10.1101/Cshperspect.A019273  0.346
2015 Achkar JM, Chan J, Casadevall A. Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis. Cold Spring Harbor Perspectives in Medicine. 5: a018432. PMID 25301934 DOI: 10.1101/Cshperspect.A018432  0.399
2015 Elshazly A, Nakouzi A, Rivera J, Casadevall A, Goldman D. A Serum Carboxypeptidase Contributes to the Processing of the Bacillus anthracis Protective Antigen Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.580  0.517
2014 Prados-Rosales R, Brown L, Casadevall A, Montalvo-Quirós S, Luque-Garcia JL. Isolation and identification of membrane vesicle-associated proteins in Gram-positive bacteria and mycobacteria. Methodsx. 1: 124-9. PMID 26150943 DOI: 10.1016/J.Mex.2014.08.001  0.3
2014 Dadachova E, Casadevall A. Radiolabeled Antibodies for Therapy of Infectious Diseases. Microbiology Spectrum. 2. PMID 26104440 DOI: 10.1128/Microbiolspec.Aid-0023-2014  0.372
2014 Wolf JM, Casadevall A. Challenges posed by extracellular vesicles from eukaryotic microbes. Current Opinion in Microbiology. 22: 73-8. PMID 25460799 DOI: 10.1016/J.Mib.2014.09.012  0.313
2014 Stukes S, Casadevall A. Visualizing non-lytic exocytosis of Cryptococcus neoformans from macrophages using digital light microscopy. Journal of Visualized Experiments : Jove. e52084. PMID 25350860 DOI: 10.3791/52084  0.793
2014 Pericolini E, Gabrielli E, Alunno A, Bartoloni Bocci E, Perito S, Chow SK, Cenci E, Casadevall A, Gerli R, Vecchiarelli A. Functional improvement of regulatory T cells from rheumatoid arthritis subjects induced by capsular polysaccharide glucuronoxylomannogalactan. Plos One. 9: e111163. PMID 25338013 DOI: 10.1371/Journal.Pone.0111163  0.591
2014 García-Rodas R, Cordero RJ, Trevijano-Contador N, Janbon G, Moyrand F, Casadevall A, Zaragoza O. Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression. Mbio. 5: e00945-14. PMID 24939886 DOI: 10.1128/Mbio.00945-14  0.354
2014 Park YD, Shin S, Panepinto J, Ramos J, Qiu J, Frases S, Albuquerque P, Cordero RJ, Zhang N, Himmelreich U, Beenhouwer D, Bennett JE, Casadevall A, Williamson PR. A role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsule. Plos Pathogens. 10: e1004037. PMID 24789368 DOI: 10.1371/Journal.Ppat.1004037  0.429
2014 Olaya-Abril A, Prados-Rosales R, McConnell MJ, Martín-Peña R, González-Reyes JA, Jiménez-Munguía I, Gómez-Gascón L, Fernández J, Luque-García JL, García-Lidón C, Estévez H, Pachón J, Obando I, Casadevall A, Pirofski LA, et al. Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae. Journal of Proteomics. 106: 46-60. PMID 24769240 DOI: 10.1016/J.Jprot.2014.04.023  0.326
2014 Chaskes S, Cammer M, Nieves E, Casadevall A. Pigment production on L-tryptophan medium by Cryptococcus gattii and Cryptococcus neoformans. Plos One. 9: e91901. PMID 24736553 DOI: 10.1371/Journal.Pone.0091901  0.315
2014 Stukes SA, Cohen HW, Casadevall A. Temporal kinetics and quantitative analysis of Cryptococcus neoformans nonlytic exocytosis. Infection and Immunity. 82: 2059-67. PMID 24595144 DOI: 10.1128/Iai.01503-14  0.809
2014 Coelho C, Bocca AL, Casadevall A. The tools for virulence of Cryptococcus neoformans. Advances in Applied Microbiology. 87: 1-41. PMID 24581388 DOI: 10.1016/B978-0-12-800261-2.00001-3  0.381
2014 Silva BM, Prados-Rosales R, Espadas-Moreno J, Wolf JM, Luque-Garcia JL, Gonçalves T, Casadevall A. Characterization of Alternaria infectoria extracellular vesicles. Medical Mycology. 52: 202-10. PMID 24576997 DOI: 10.1093/Mmy/Myt003  0.314
2014 Albuquerque PC, Fonseca FL, Dutra FF, Bozza MT, Frases S, Casadevall A, Rodrigues ML. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct. Future Microbiology. 9: 147-61. PMID 24571070 DOI: 10.2217/Fmb.13.163  0.311
2014 Rivera J, Sellers RS, Zeng W, van Rooijen N, Casadevall A, Goldman DL. Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage. The Journal of Biological Chemistry. 289: 7131-41. PMID 24478317 DOI: 10.1074/Jbc.M113.524900  0.516
2014 Bournazos S, Chow SK, Abboud N, Casadevall A, Ravetch JV. Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity. The Journal of Clinical Investigation. 124: 725-9. PMID 24401277 DOI: 10.1172/Jci72676  0.749
2014 Brojatsch J, Casadevall A, Goldman DL. Molecular determinants for a cardiovascular collapse in anthrax. Frontiers in Bioscience (Elite Edition). 6: 139-47. PMID 24389148 DOI: 10.2741/E697  0.323
2014 Albuquerque P, Nicola AM, Nieves E, Paes HC, Williamson PR, Silva-Pereira I, Casadevall A. Quorum sensing-mediated, cell density-dependent regulation of growth and virulence in Cryptococcus neoformans. Mbio. 5: e00986-13. PMID 24381301 DOI: 10.1128/Mbio.00986-13  0.356
2014 Rivera J, Morgenstern A, Bruchertseifer F, Kearney JF, Turnbough CL, Dadachova E, Casadevall A. Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores. Antimicrobial Agents and Chemotherapy. 58: 1813-5. PMID 24379209 DOI: 10.1128/Aac.01266-13  0.566
2014 Coelho C, Bocca AL, Casadevall A. The intracellular life of Cryptococcus neoformans. Annual Review of Pathology. 9: 219-38. PMID 24050625 DOI: 10.1146/Annurev-Pathol-012513-104653  0.375
2014 Alunno A, Pericolini E, Gabrielli E, Bistoni O, Caterbi S, Bartoloni E, Terenzi R, Valentini E, La Paglia G, Chow S, Casadevall A, Vecchiarelli A, Gerli R. A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis Annals of the Rheumatic Diseases. 73: A71.1-A71. DOI: 10.1136/Annrheumdis-2013-205124.162  0.591
2013 Rath P, Huang C, Wang T, Wang T, Li H, Prados-Rosales R, Elemento O, Casadevall A, Nathan CF. Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America. 110: E4790-7. PMID 24248369 DOI: 10.1073/Pnas.1320118110  0.306
2013 Bryan RA, Jiang Z, Morgenstern A, Bruchertseifer F, Casadevall A, Dadachova E. Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells. Future Microbiology. 8: 1081-9. PMID 24020737 DOI: 10.2217/Fmb.13.79  0.424
2013 Andes D, Casadevall A. Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitis. Fungal Genetics and Biology : Fg & B. 61: 143-5. PMID 24012946 DOI: 10.1016/J.Fgb.2013.08.014  0.308
2013 Cordero RJ, Bergman A, Casadevall A. Temporal behavior of capsule enlargement by Cryptococcus neoformans. Eukaryotic Cell. 12: 1383-8. PMID 23954840 DOI: 10.1128/Ec.00163-13  0.333
2013 Eryilmaz E, Janda A, Kim J, Cordero RJ, Cowburn D, Casadevall A. Global structures of IgG isotypes expressing identical variable regions. Molecular Immunology. 56: 588-98. PMID 23911417 DOI: 10.1016/J.Molimm.2013.06.006  0.71
2013 McClelland EE, Hobbs LM, Rivera J, Casadevall A, Potts WK, Smith JM, Ory JJ. The role of host gender in the pathogenesis of Cryptococcus neoformans infections. Plos One. 8: e63632. PMID 23741297 DOI: 10.1371/Journal.Pone.0063632  0.549
2013 Kania G, Siegert S, Behnke S, Prados-Rosales R, Casadevall A, Lüscher TF, Luther SA, Kopf M, Eriksson U, Blyszczuk P. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis. Circulation. 127: 2285-94. PMID 23671208 DOI: 10.1161/Circulationaha.112.000434  0.316
2013 Xia Y, Janda A, Eryilmaz E, Casadevall A, Putterman C. The constant region affects antigen binding of antibodies to DNA by altering secondary structure. Molecular Immunology. 56: 28-37. PMID 23665381 DOI: 10.1016/J.Molimm.2013.04.004  0.64
2013 Garcia-Solache MA, Izquierdo-Garcia D, Smith C, Bergman A, Casadevall A. Fungal virulence in a lepidopteran model is an emergent property with deterministic features. Mbio. 4: e00100-13. PMID 23631914 DOI: 10.1128/Mbio.00100-13  0.353
2013 Fonseca FL, Guimarães AJ, Kmetzsch L, Dutra FF, Silva FD, Taborda CP, Araujo Gde S, Frases S, Staats CC, Bozza MT, Schrank A, Vainstein MH, Nimrichter L, Casadevall A, Rodrigues ML. Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis. Fungal Genetics and Biology : Fg & B. 60: 64-73. PMID 23608320 DOI: 10.1016/J.Fgb.2013.04.005  0.417
2013 Chow SK, Smith C, MacCarthy T, Pohl MA, Bergman A, Casadevall A. Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies. Cell Host & Microbe. 13: 417-28. PMID 23601104 DOI: 10.1016/J.Chom.2013.03.001  0.681
2013 Ziegenbalg A, Prados-Rosales R, Jenny-Avital ER, Kim RS, Casadevall A, Achkar JM. Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker. Tuberculosis (Edinburgh, Scotland). 93: 448-55. PMID 23562367 DOI: 10.1016/J.Tube.2013.03.001  0.316
2013 Derengowski Lda S, Paes HC, Albuquerque P, Tavares AH, Fernandes L, Silva-Pereira I, Casadevall A. The transcriptional response of Cryptococcus neoformans to ingestion by Acanthamoeba castellanii and macrophages provides insights into the evolutionary adaptation to the mammalian host. Eukaryotic Cell. 12: 761-74. PMID 23524994 DOI: 10.1128/Ec.00073-13  0.389
2013 Pohl MA, Rivera J, Nakouzi A, Chow SK, Casadevall A. Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays. Infection and Immunity. 81: 1880-8. PMID 23509144 DOI: 10.1128/Iai.01328-12  0.761
2013 Achkar JM, Casadevall A. Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host & Microbe. 13: 250-62. PMID 23498951 DOI: 10.1016/J.Chom.2013.02.009  0.342
2013 Casadevall A, Pirofski LA. Exserohilum rostratum fungal meningitis associated with methylprednisolone injections. Future Microbiology. 8: 135-7. PMID 23374119 DOI: 10.2217/Fmb.12.138  0.346
2013 Pericolini E, Alunno A, Gabrielli E, Bartoloni E, Cenci E, Chow SK, Bistoni G, Casadevall A, Gerli R, Vecchiarelli A. The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients. Plos One. 8: e53336. PMID 23308194 DOI: 10.1371/Journal.Pone.0053336  0.6
2013 Cordero RJ, Pontes B, Frases S, Nakouzi AS, Nimrichter L, Rodrigues ML, Viana NB, Casadevall A. Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties. Journal of Immunology (Baltimore, Md. : 1950). 190: 317-23. PMID 23233725 DOI: 10.4049/Jimmunol.1202324  0.39
2013 Jandl T, Revskaya E, Jiang Z, Harris M, Dorokhova O, Tsukrov D, Casadevall A, Dadachova E. Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy. Nuclear Medicine and Biology. 40: 177-81. PMID 23146306 DOI: 10.1016/J.Nucmedbio.2012.10.006  0.312
2013 Chatterjee S, Prados-Rosales R, Frases-Carvajal S, Tan S, Itin B, Wang H, Casadevall A, Stark RE. Elucidating the Structural Framework of Synthetic and Fungal Melanins by Solid-State NMR Biophysical Journal. 104: 181a. DOI: 10.1016/J.Bpj.2012.11.1018  0.302
2012 Albuquerque PC, Cordero RJ, Fonseca FL, Peres da Silva R, Ramos CL, Miranda KR, Casadevall A, Puccia R, Nosanchuk JD, Nimrichter L, Guimaraes AJ, Rodrigues ML. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan. Fungal Genetics and Biology : Fg & B. 49: 943-54. PMID 23010152 DOI: 10.1016/J.Fgb.2012.09.002  0.362
2012 Robertson EJ, Wolf JM, Casadevall A. EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans. Applied and Environmental Microbiology. 78: 7977-84. PMID 22941091 DOI: 10.1128/Aem.01953-12  0.311
2012 Janda A, Eryilmaz E, Nakouzi A, Cowburn D, Casadevall A. Variable region identical immunoglobulins differing in isotype express different paratopes. The Journal of Biological Chemistry. 287: 35409-17. PMID 22930758 DOI: 10.1074/Jbc.M112.404483  0.728
2012 Xia Y, Pawar RD, Nakouzi AS, Herlitz L, Broder A, Liu K, Goilav B, Fan M, Wang L, Li QZ, Casadevall A, Putterman C. The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. Journal of Autoimmunity. 39: 398-411. PMID 22841793 DOI: 10.1016/J.Jaut.2012.06.005  0.336
2012 Casadevall A, Janda A. Immunoglobulin isotype influences affinity and specificity. Proceedings of the National Academy of Sciences of the United States of America. 109: 12272-3. PMID 22826242 DOI: 10.1073/Pnas.1209750109  0.644
2012 Chow SK, Casadevall A. Monoclonal antibodies and toxins--a perspective on function and isotype. Toxins. 4: 430-54. PMID 22822456 DOI: 10.3390/Toxins4060430  0.675
2012 Chatterjee S, Prados-Rosales R, Frases S, Itin B, Casadevall A, Stark RE. Using solid-state NMR to monitor the molecular consequences of Cryptococcus neoformans melanization with different catecholamine precursors. Biochemistry. 51: 6080-8. PMID 22765382 DOI: 10.1021/Bi300325M  0.307
2012 Nicola AM, Albuquerque P, Martinez LR, Dal-Rosso RA, Saylor C, De Jesus M, Nosanchuk JD, Casadevall A. Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Infection and Immunity. 80: 3065-76. PMID 22710871 DOI: 10.1128/Iai.00358-12  0.816
2012 Casadevall A, Pirofski LA. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host & Microbe. 11: 447-56. PMID 22607798 DOI: 10.1016/J.Chom.2012.04.004  0.412
2012 Ramos CL, Fonseca FL, Rodrigues J, Guimarães AJ, Cinelli LP, Miranda K, Nimrichter L, Casadevall A, Travassos LR, Rodrigues ML. Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties. Eukaryotic Cell. 11: 1086-94. PMID 22562469 DOI: 10.1128/Ec.00001-12  0.317
2012 Muhammed M, Feldmesser M, Shubitz LF, Lionakis MS, Sil A, Wang Y, Glavis-Bloom J, Lewis RE, Galgiani JN, Casadevall A, Kontoyiannis DP, Mylonakis E. Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus. Virulence. 3: 329-38. PMID 22546902 DOI: 10.4161/Viru.20142  0.31
2012 McClelland EE, Casadevall A. Strain-related differences in antibody-mediated changes in gene expression are associated with differences in capsule and location of binding. Fungal Genetics and Biology : Fg & B. 49: 227-34. PMID 22327012 DOI: 10.1016/J.Fgb.2012.01.006  0.324
2012 Wolf JM, Rivera J, Casadevall A. Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles. Cellular Microbiology. 14: 762-73. PMID 22289081 DOI: 10.1111/J.1462-5822.2012.01757.X  0.543
2012 Albuquerque P, Casadevall A. Quorum sensing in fungi--a review. Medical Mycology. 50: 337-45. PMID 22268493 DOI: 10.3109/13693786.2011.652201  0.337
2012 Nicola AM, Casadevall A. In vitro measurement of phagocytosis and killing of Cryptococcus neoformans by macrophages Methods in Molecular Biology. 844: 189-197. PMID 22262444 DOI: 10.1007/978-1-61779-527-5_14  0.375
2012 Araujo Gde S, Fonseca FL, Pontes B, Torres A, Cordero RJ, Zancopé-Oliveira RM, Casadevall A, Viana NB, Nimrichter L, Rodrigues ML, Garcia ES, Souza Wd, Frases S. Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells. Plos One. 7: e29561. PMID 22253734 DOI: 10.1371/Journal.Pone.0029561  0.406
2012 Coelho C, Tesfa L, Zhang J, Rivera J, Gonçalves T, Casadevall A. Analysis of cell cycle and replication of mouse macrophages after in vivo and in vitro Cryptococcus neoformans infection using laser scanning cytometry. Infection and Immunity. 80: 1467-78. PMID 22252872 DOI: 10.1128/Iai.06332-11  0.58
2012 Casadevall A, Pirofski LA. A new synthesis for antibody-mediated immunity. Nature Immunology. 13: 21-8. PMID 22179281 DOI: 10.1038/Ni.2184  0.378
2012 Eisenman HC, Casadevall A. Synthesis and assembly of fungal melanin. Applied Microbiology and Biotechnology. 93: 931-40. PMID 22173481 DOI: 10.1007/S00253-011-3777-2  0.318
2012 Casadevall A. Amoeba provide insight into the origin of virulence in pathogenic fungi Advances in Experimental Medicine and Biology. 710: 1-10. PMID 22127880 DOI: 10.1007/978-1-4419-5638-5_1  0.346
2012 Goldman DL, Li X, Tsirilakis K, Andrade C, Casadevall A, Vicencio AG. Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. 42: 523-30. PMID 22092749 DOI: 10.1111/J.1365-2222.2011.03886.X  0.304
2012 Bryan RA, Guimaraes AJ, Hopcraft S, Jiang Z, Bonilla K, Morgenstern A, Bruchertseifer F, Del Poeta M, Torosantucci A, Cassone A, Nosanchuk JD, Casadevall A, Dadachova E. Toward Developing a Universal Treatment for Fungal Disease Using Radioimmunotherapy Targeting Common Fungal Antigens Mycopathologia. 173: 463-471. PMID 22048869 DOI: 10.1007/S11046-011-9476-9  0.406
2012 Jiang Z, Bryan RA, Morgenstern A, Bruchertseifer F, Casadevall A, Dadachova E. Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent mice. Antimicrobial Agents and Chemotherapy. 56: 552-4. PMID 22005995 DOI: 10.1128/Aac.00473-11  0.348
2012 Tsirilakis K, Kim C, Vicencio AG, Andrade C, Casadevall A, Goldman DL. Methylxanthine inhibit fungal chitinases and exhibit antifungal activity. Mycopathologia. 173: 83-91. PMID 21968902 DOI: 10.1007/S11046-011-9483-X  0.355
2012 Chatterjee S, Prados-Rosales R, Tan S, Itin B, Wang H, Casadevall A, Stark RE. Probing the Molecular Architecture and Assembly of Synthetic and Fungal Melanins with Solid-State NMR Biophysical Journal. 102: 389a. DOI: 10.1016/J.Bpj.2011.11.2126  0.31
2011 Rodrigues ML, Nosanchuk JD, Schrank A, Vainstein MH, Casadevall A, Nimrichter L. Vesicular transport systems in fungi Future Microbiology. 6: 1371-1381. PMID 22082294 DOI: 10.2217/Fmb.11.112  0.332
2011 Cordero RJ, Pontes B, Guimarães AJ, Martinez LR, Rivera J, Fries BC, Nimrichter L, Rodrigues ML, Viana NB, Casadevall A. Chronological aging is associated with biophysical and chemical changes in the capsule of Cryptococcus neoformans. Infection and Immunity. 79: 4990-5000. PMID 21968999 DOI: 10.1128/Iai.05789-11  0.669
2011 Khajo A, Bryan RA, Friedman M, Burger RM, Levitsky Y, Casadevall A, Magliozzo RS, Dadachova E. Protection of melanized Cryptococcus neoformans from lethal dose gamma irradiation involves changes in melanin's chemical structure and paramagnetism. Plos One. 6: e25092. PMID 21966422 DOI: 10.1371/Journal.Pone.0025092  0.313
2011 García-Rodas R, Casadevall A, Rodríguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. Plos One. 6: e24485. PMID 21915338 DOI: 10.1371/Journal.Pone.0024485  0.407
2011 Vecchiarelli A, Pericolini E, Gabrielli E, Chow SK, Bistoni F, Cenci E, Casadevall A. Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy. Immunotherapy. 3: 997-1005. PMID 21843086 DOI: 10.2217/Imt.11.86  0.7
2011 Nicola AM, Robertson EJ, Albuquerque P, Derengowski Lda S, Casadevall A. Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH. Mbio. 2. PMID 21828219 DOI: 10.1128/Mbio.00167-11  0.356
2011 Dadachova E, Casadevall A. Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections. Interdisciplinary Perspectives On Infectious Diseases. 2011: 830286. PMID 21747848 DOI: 10.1155/2011/830286  0.372
2011 Eisenman HC, Chow SK, Tsé KK, McClelland EE, Casadevall A. The effect of L-DOPA on Cryptococcus neoformans growth and gene expression. Virulence. 2: 329-36. PMID 21705857 DOI: 10.4161/Viru.2.4.16136  0.628
2011 Chrisman CJ, Albuquerque P, Guimaraes AJ, Nieves E, Casadevall A. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. Plos Pathogens. 7: e1002047. PMID 21637814 DOI: 10.1371/Journal.Ppat.1002047  0.816
2011 Kmetzsch L, Joffe LS, Staats CC, de Oliveira DL, Fonseca FL, Cordero RJ, Casadevall A, Nimrichter L, Schrank A, Vainstein MH, Rodrigues ML. Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence. Molecular Microbiology. 81: 206-18. PMID 21542865 DOI: 10.1111/J.1365-2958.2011.07686.X  0.389
2011 Liu TB, Wang Y, Stukes S, Chen Q, Casadevall A, Xue C. The F-Box protein Fbp1 regulates sexual reproduction and virulence in Cryptococcus neoformans. Eukaryotic Cell. 10: 791-802. PMID 21478432 DOI: 10.1128/Ec.00004-11  0.78
2011 Prados-Rosales R, Baena A, Martinez LR, Luque-Garcia J, Kalscheuer R, Veeraraghavan U, Camara C, Nosanchuk JD, Besra GS, Chen B, Jimenez J, Glatman-Freedman A, Jacobs WR, Porcelli SA, Casadevall A. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. The Journal of Clinical Investigation. 121: 1471-83. PMID 21364279 DOI: 10.1172/Jci44261  0.575
2011 Chow SK, Casadevall A. Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis. Vaccine. 29: 1891-8. PMID 21238568 DOI: 10.1016/J.Vaccine.2010.12.134  0.69
2011 Cordero RJ, Frases S, Guimaräes AJ, Rivera J, Casadevall A. Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Molecular Microbiology. 79: 1101-17. PMID 21208301 DOI: 10.1111/J.1365-2958.2010.07511.X  0.534
2011 Lye LF, Kang SO, Nosanchuk JD, Casadevall A, Beverley SM. Phenylalanine hydroxylase (PAH) from the lower eukaryote Leishmania major. Molecular and Biochemical Parasitology. 175: 58-67. PMID 20887755 DOI: 10.1016/J.Molbiopara.2010.09.004  0.324
2010 Oliveira DL, Nakayasu ES, Joffe LS, Guimarães AJ, Sobreira TJ, Nosanchuk JD, Cordero RJ, Frases S, Casadevall A, Almeida IC, Nimrichter L, Rodrigues ML. Biogenesis of extracellular vesicles in yeast: Many questions with few answers. Communicative & Integrative Biology. 3: 533-5. PMID 21331232 DOI: 10.4161/Cib.3.6.12756  0.3
2010 Jesus MD, Nicola AM, Chow SK, Lee IR, Nong S, Specht CA, Levitz SM, Casadevall A. Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence. 1: 500-8. PMID 21178496 DOI: 10.4161/Viru.1.6.13451  0.691
2010 Rivera J, Cordero RJ, Nakouzi AS, Frases S, Nicola A, Casadevall A. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proceedings of the National Academy of Sciences of the United States of America. 107: 19002-7. PMID 20956325 DOI: 10.1073/Pnas.1008843107  0.582
2010 Abboud N, Chow SK, Saylor C, Janda A, Ravetch JV, Scharff MD, Casadevall A. A requirement for FcγR in antibody-mediated bacterial toxin neutralization. The Journal of Experimental Medicine. 207: 2395-405. PMID 20921285 DOI: 10.1084/Jem.20100995  0.799
2010 Pericolini E, Gabrielli E, Bistoni G, Cenci E, Perito S, Chow SK, Riuzzi F, Donato R, Casadevall A, Vecchiarelli A. Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage. Plos One. 5: e12720. PMID 20856869 DOI: 10.1371/Journal.Pone.0012720  0.605
2010 Luo Y, Casadevall A. Intracellular cryptococci suppress Fc-mediated cyclin D1 elevation. Communicative & Integrative Biology. 3: 390-1. PMID 20798836 DOI: 10.4161/Cib.3.4.12090  0.497
2010 Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. An insight into the antifungal pipeline: selected new molecules and beyond. Nature Reviews. Drug Discovery. 9: 719-27. PMID 20725094 DOI: 10.1038/Nrd3074  0.31
2010 Garcia-Solache MA, Casadevall A. Global warming will bring new fungal diseases for mammals. Mbio. 1. PMID 20689745 DOI: 10.1128/Mbio.00061-10  0.332
2010 Chrisman CJ, Alvarez M, Casadevall A. Phagocytosis of Cryptococcus neoformans by, and nonlytic exocytosis from, Acanthamoeba castellanii. Applied and Environmental Microbiology. 76: 6056-62. PMID 20675457 DOI: 10.1128/Aem.00812-10  0.81
2010 Muehlbauer SM, Lima H, Goldman DL, Jacobson LS, Rivera J, Goldberg MF, Palladino MA, Casadevall A, Brojatsch J. Proteasome inhibitors prevent caspase-1-mediated disease in rodents challenged with anthrax lethal toxin. The American Journal of Pathology. 177: 735-43. PMID 20595632 DOI: 10.2353/Ajpath.2010.090828  0.733
2010 Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. Fungal cell gigantism during mammalian infection. Plos Pathogens. 6: e1000945. PMID 20585557 DOI: 10.1371/Journal.Ppat.1000945  0.396
2010 Fonseca FL, Nohara LL, Cordero RJ, Frases S, Casadevall A, Almeida IC, Nimrichter L, Rodrigues ML. Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter. Infection and Immunity. 78: 3861-70. PMID 20547742 DOI: 10.1128/Iai.00111-10  0.341
2010 Winterroth L, Rivera J, Nakouzi AS, Dadachova E, Casadevall A. Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax. Infection and Immunity. 78: 2890-8. PMID 20385755 DOI: 10.1128/Iai.01101-09  0.596
2010 McClelland EE, Nicola AM, Prados-Rosales R, Casadevall A. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. The Journal of Clinical Investigation. 120: 1355-61. PMID 20335660 DOI: 10.1172/Jci38322  0.371
2010 Janda A, Casadevall A. Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure. Molecular Immunology. 47: 1421-5. PMID 20299100 DOI: 10.1016/J.Molimm.2010.02.018  0.657
2010 Frager SZ, Chrisman CJ, Shakked R, Casadevall A. Paramecium species ingest and kill the cells of the human pathogenic fungus Cryptococcus neoformans. Medical Mycology. 48: 775-9. PMID 20233022 DOI: 10.3109/13693780903451810  0.799
2010 Oliveira DL, Freire-de-Lima CG, Nosanchuk JD, Casadevall A, Rodrigues ML, Nimrichter L. Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions. Infection and Immunity. 78: 1601-9. PMID 20145096 DOI: 10.1128/Iai.01171-09  0.356
2010 Guimarães AJ, Frases S, Cordero RJ, Nimrichter L, Casadevall A, Nosanchuk JD. Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo. Cellular Microbiology. 12: 740-53. PMID 20070311 DOI: 10.1111/J.1462-5822.2010.01430.X  0.328
2010 De Jesus M, Chow SK, Cordero RJ, Frases S, Casadevall A. Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable. Eukaryotic Cell. 9: 1018-28. PMID 20061411 DOI: 10.1128/Ec.00268-09  0.751
2010 Luo Y, Pollard JW, Casadevall A. Fcgamma receptor cross-linking stimulates cell proliferation of macrophages via the ERK pathway. The Journal of Biological Chemistry. 285: 4232-42. PMID 19996316 DOI: 10.1074/Jbc.M109.037168  0.437
2010 Saylor CA, Dadachova E, Casadevall A. Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors. Journal of Immunology (Baltimore, Md. : 1950). 184: 336-43. PMID 19949107 DOI: 10.4049/Jimmunol.0902752  0.801
2010 Martinez LR, Mihu MR, Han G, Frases S, Cordero RJ, Casadevall A, Friedman AJ, Friedman JM, Nosanchuk JD. The use of chitosan to damage Cryptococcus neoformans biofilms. Biomaterials. 31: 669-79. PMID 19819009 DOI: 10.1016/J.Biomaterials.2009.09.087  0.559
2010 Rodrigues ML, Fonseca FL, Frases S, Casadevall A, Nimrichter L. The still obscure attributes of cryptococcal glucuronoxylomannan. Medical Mycology. 47: 783-8. PMID 19343609 DOI: 10.3109/13693780902788621  0.385
2010 Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. Correction: Fungal Cell Gigantism during Mammalian Infection Plos Pathogens. 6. DOI: 10.1371/Annotation/0675044C-D80F-456F-Bb63-4F85Fb1D0C33  0.339
2009 Saylor C, Dadachova E, Casadevall A. Monoclonal antibody-based therapies for microbial diseases Vaccine. 27. PMID 20006139 DOI: 10.1016/J.Vaccine.2009.09.105  0.776
2009 Oliveira DL, Nimrichter L, Miranda K, Frases S, Faull KF, Casadevall A, Rodrigues ML. Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan. Fungal Genetics and Biology : Fg & B. 46: 956-63. PMID 19747978 DOI: 10.1016/J.Fgb.2009.09.001  0.31
2009 Eisenman HC, Frases S, Nicola AM, Rodrigues ML, Casadevall A. Vesicle-associated melanization in Cryptococcus neoformans. Microbiology (Reading, England). 155: 3860-7. PMID 19729402 DOI: 10.1099/Mic.0.032854-0  0.34
2009 Silva MB, Thomaz L, Marques AF, Svidzinski AE, Nosanchuk JD, Casadevall A, Travassos LR, Taborda CP. Resistance of melanized yeast cells of Paracoccidioides brasiliensis to antimicrobial oxidants and inhibition of phagocytosis using carbohydrates and monoclonal antibody to CD18. MemóRias Do Instituto Oswaldo Cruz. 104: 644-8. PMID 19722091 DOI: 10.1590/S0074-02762009000400019  0.384
2009 Casadevall A, Pirofski LA. Virulence factors and their mechanisms of action: the view from a damage-response framework. Journal of Water and Health. 7: S2-S18. PMID 19717929 DOI: 10.2166/Wh.2009.036  0.328
2009 Rivera J, Nakouzi AS, Morgenstern A, Bruchertseifer F, Dadachova E, Casadevall A. Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax. Antimicrobial Agents and Chemotherapy. 53: 4860-8. PMID 19704133 DOI: 10.1128/Aac.01269-08  0.601
2009 Frases S, Pontes B, Nimrichter L, Rodrigues ML, Viana NB, Casadevall A. The elastic properties of the Cryptococcus neoformans capsule. Biophysical Journal. 97: 937-45. PMID 19686640 DOI: 10.1016/J.Bpj.2009.04.043  0.34
2009 De Jesus M, Nicola AM, Frases S, Lee IR, Mieses S, Casadevall A. Galactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage. Journal of Immunology (Baltimore, Md. : 1950). 183: 3885-94. PMID 19684080 DOI: 10.4049/Jimmunol.0900449  0.673
2009 Luo Y, Isaac BM, Casadevall A, Cox D. Phagocytosis inhibits F-actin-enriched membrane protrusions stimulated by fractalkine (CX3CL1) and colony-stimulating factor 1. Infection and Immunity. 77: 4487-95. PMID 19620351 DOI: 10.1128/Iai.00530-09  0.507
2009 Abboud N, De Jesus M, Nakouzi A, Cordero RJ, Pujato M, Fiser A, Rivera J, Casadevall A. Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies. The Journal of Biological Chemistry. 284: 25077-86. PMID 19617628 DOI: 10.1074/Jbc.M109.022061  0.783
2009 Fonseca FL, Nimrichter L, Cordero RJ, Frases S, Rodrigues J, Goldman DL, Andruszkiewicz R, Milewski S, Travassos LR, Casadevall A, Rodrigues ML. Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans. Eukaryotic Cell. 8: 1543-53. PMID 19617395 DOI: 10.1128/Ec.00142-09  0.387
2009 Nicola AM, Frases S, Casadevall A. Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule. Eukaryotic Cell. 8: 1373-80. PMID 19465562 DOI: 10.1128/Ec.00044-09  0.306
2009 Nakouzi A, Zhang T, Oscarson S, Casadevall A. The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies. Vaccine. 27: 3513-8. PMID 19464529 DOI: 10.1016/J.Vaccine.2009.03.089  0.366
2009 Zaragoza O, Rodrigues ML, De Jesus M, Frases S, Dadachova E, Casadevall A. The capsule of the fungal pathogen Cryptococcus neoformans. Advances in Applied Microbiology. 68: 133-216. PMID 19426855 DOI: 10.1016/S0065-2164(09)01204-0  0.658
2009 Pericolini E, Gabrielli E, Cenci E, De Jesus M, Bistoni F, Casadevall A, Vecchiarelli A. Involvement of glycoreceptors in galactoxylomannan-induced T cell death. Journal of Immunology (Baltimore, Md. : 1950). 182: 6003-10. PMID 19414751 DOI: 10.4049/Jimmunol.0803833  0.617
2009 Revskaya E, Jongco AM, Sellers RS, Howell RC, Koba W, Guimaraes AJ, Nosanchuk JD, Casadevall A, Dadachova E. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2373-9. PMID 19293257 DOI: 10.1158/1078-0432.Ccr-08-2376  0.331
2009 Fonseca FL, Frases S, Casadevall A, Fischman-Gompertz O, Nimrichter L, Rodrigues ML. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan. Fungal Genetics and Biology : Fg & B. 46: 496-505. PMID 19285564 DOI: 10.1016/J.Fgb.2009.03.003  0.379
2009 Alvarez M, Burn T, Luo Y, Pirofski LA, Casadevall A. The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes. Bmc Microbiology. 9: 51. PMID 19265539 DOI: 10.1186/1471-2180-9-51  0.715
2009 Robertson EJ, Casadevall A. Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation. Applied and Environmental Microbiology. 75: 2528-33. PMID 19251903 DOI: 10.1128/Aem.02846-08  0.356
2009 Panepinto J, Komperda K, Frases S, Park YD, Djordjevic JT, Casadevall A, Williamson PR. Sec6-dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans. Molecular Microbiology. 71: 1165-76. PMID 19210702 DOI: 10.1111/J.1365-2958.2008.06588.X  0.349
2009 Dadachova E, Casadevall A. Radioimmunotherapy of Infectious Diseases Seminars in Nuclear Medicine. 39: 146-153. PMID 19187806 DOI: 10.1053/J.Semnuclmed.2008.10.007  0.403
2009 Frases S, Pontes B, Nimrichter L, Viana NB, Rodrigues ML, Casadevall A. Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules. Proceedings of the National Academy of Sciences of the United States of America. 106: 1228-33. PMID 19164571 DOI: 10.1073/Pnas.0808995106  0.322
2009 Bryan RA, Jiang Z, Huang X, Morgenstern A, Bruchertseifer F, Sellers R, Casadevall A, Dadachova E. Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells. Antimicrobial Agents and Chemotherapy. 53: 1679-82. PMID 19139285 DOI: 10.1128/Aac.01334-08  0.301
2009 Bliska JB, Casadevall A. Intracellular pathogenic bacteria and fungi--a case of convergent evolution? Nature Reviews. Microbiology. 7: 165-71. PMID 19098923 DOI: 10.1038/Nrmicro2049  0.33
2009 De Jesus M, Nicola AM, Rodrigues ML, Janbon G, Casadevall A. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryotic Cell. 8: 96-103. PMID 18952901 DOI: 10.1128/Ec.00331-08  0.692
2008 Dadachova E, Rivera J, Revskaya E, Nakouzi A, Cahill SM, Blumenstein M, Xiao H, Rykunov D, Casadevall A. In vitro evaluation, biodistribution and scintigraphic imaging in mice of radiolabeled anthrax toxins. Nuclear Medicine and Biology. 35: 755-61. PMID 18848660 DOI: 10.1016/J.Nucmedbio.2008.07.001  0.549
2008 Pirofski LA, Casadevall A. The damage-response framework of microbial pathogenesis and infectious diseases. Advances in Experimental Medicine and Biology. 635: 135-46. PMID 18841709 DOI: 10.1007/978-0-387-09550-9_11  0.317
2008 Nakouzi A, Rivera J, Rest RF, Casadevall A. Passive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis. Bmc Microbiology. 8: 159. PMID 18811967 DOI: 10.1186/1471-2180-8-159  0.6
2008 Dam TK, Torres M, Brewer CF, Casadevall A. Isothermal titration calorimetry reveals differential binding thermodynamics of variable region-identical antibodies differing in constant region for a univalent ligand. The Journal of Biological Chemistry. 283: 31366-70. PMID 18806257 DOI: 10.1074/Jbc.M806473200  0.652
2008 Luo Y, Alvarez M, Xia L, Casadevall A. The outcome of phagocytic cell division with infectious cargo depends on single phagosome formation. Plos One. 3: e3219. PMID 18795151 DOI: 10.1371/Journal.Pone.0003219  0.645
2008 Casadevall A. Evolution of intracellular pathogens Annual Review of Microbiology. 62: 19-33. PMID 18785836 DOI: 10.1146/Annurev.Micro.61.080706.093305  0.329
2008 Rakesh V, Schweitzer AD, Zaragoza O, Bryan R, Wong K, Datta A, Casadevall A, Dadachova E. Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans. The Journal of Physical Chemistry. B. 112: 8514-22. PMID 18588334 DOI: 10.1021/Jp8018205  0.369
2008 Nicola AM, Casadevall A, Goldman DL. Fungal killing by mammalian phagocytic cells. Current Opinion in Microbiology. 11: 313-7. PMID 18573683 DOI: 10.1016/J.Mib.2008.05.011  0.377
2008 Martinez LR, Ibom DC, Casadevall A, Fries BC. Characterization of phenotypic switching in Cryptococcus neoformans biofilms. Mycopathologia. 166: 175-80. PMID 18568421 DOI: 10.1007/S11046-008-9133-0  0.575
2008 Zaragoza O, Chrisman CJ, Castelli MV, Frases S, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cellular Microbiology. 10: 2043-57. PMID 18554313 DOI: 10.1111/J.1462-5822.2008.01186.X  0.798
2008 Dadachova E, Revskaya E, Sesay MA, Damania H, Boucher R, Sellers RS, Howell RC, Burns L, Thornton GB, Natarajan A, Mirick GR, DeNardo SJ, DeNardo GL, Casadevall A. Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice. Cancer Biology & Therapy. 7: 1116-27. PMID 18535406 DOI: 10.4161/Cbt.7.7.6197  0.323
2008 Abboud N, Casadevall A. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background. Clinical and Vaccine Immunology : Cvi. 15: 1115-23. PMID 18480236 DOI: 10.1128/Cvi.00015-08  0.666
2008 Goldman DL, Zeng W, Rivera J, Nakouzzi A, Casadevall A. Human serum contains a protease that protects against cytotoxic activity of Bacillus anthracis lethal toxin in vitro. Clinical and Vaccine Immunology : Cvi. 15: 970-3. PMID 18448623 DOI: 10.1128/Cvi.00064-08  0.558
2008 Albuquerque PC, Nakayasu ES, Rodrigues ML, Frases S, Casadevall A, Zancope-Oliveira RM, Almeida IC, Nosanchuk JD. Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes. Cellular Microbiology. 10: 1695-710. PMID 18419773 DOI: 10.1111/J.1462-5822.2008.01160.X  0.327
2008 Alvarez M, Saylor C, Casadevall A. Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation. Cellular Microbiology. 10: 1622-33. PMID 18384661 DOI: 10.1111/J.1462-5822.2008.01152.X  0.83
2008 Zhong J, Frases S, Wang H, Casadevall A, Stark RE. Following fungal melanin biosynthesis with solid-state NMR: biopolymer molecular structures and possible connections to cell-wall polysaccharides. Biochemistry. 47: 4701-10. PMID 18370403 DOI: 10.1021/Bi702093R  0.32
2008 De Jesus M, Park CG, Su Y, Goldman DL, Steinman RM, Casadevall A. Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1. Medical Mycology. 46: 153-62. PMID 18324494 DOI: 10.1080/13693780701747182  0.649
2008 Maglione PJ, Xu J, Casadevall A, Chan J. Fcγ receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection Journal of Immunology. 180: 3329-3338. PMID 18292558 DOI: 10.4049/Jimmunol.180.5.3329  0.34
2008 Zarebski LM, Vaughan K, Sidney J, Peters B, Grey H, Janda KD, Casadevall A, Sette A. Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum. Expert Review of Vaccines. 7: 55-74. PMID 18251694 DOI: 10.1586/14760584.7.1.55  0.366
2008 Torres M, Casadevall A. The immunoglobulin constant region contributes to affinity and specificity. Trends in Immunology. 29: 91-7. PMID 18191616 DOI: 10.1016/J.It.2007.11.004  0.664
2008 Zhuang D, Hage C, De Jesus M, Hackett E, Durkin M, Davis TE, Casadevall A, Wheat LJ. Cryptococcal glucoxylomannan does not exhibit cross-reactivity in the MVista Histoplasma antigen enzyme immunoassay. Clinical and Vaccine Immunology : Cvi. 15: 392-3. PMID 18077616 DOI: 10.1128/Cvi.00383-07  0.629
2008 Rodrigues ML, Alvarez M, Fonseca FL, Casadevall A. Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryotic Cell. 7: 602-9. PMID 18039942 DOI: 10.1128/Ec.00307-07  0.621
2008 Rodrigues ML, Nakayasu ES, Oliveira DL, Nimrichter L, Nosanchuk JD, Almeida IC, Casadevall A. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryotic Cell. 7: 58-67. PMID 18039940 DOI: 10.1128/Ec.00370-07  0.332
2008 Chaskes S, Frases S, Cammer M, Gerfen G, Casadevall A. Growth and pigment production on D-tryptophan medium by Cryptococcus gattii, Cryptococcus neoformans, and Candida albicans. Journal of Clinical Microbiology. 46: 255-64. PMID 17989195 DOI: 10.1128/Jcm.01721-07  0.316
2008 Luo Y, Casadevall A. Fc-RECEPTOR CROSSLINKING STIMULATES CELL CYCLE PROGRESSION OF MACROPHAGES VIA THE ERK PATHWAY The Faseb Journal. 22: 545-545. DOI: 10.1096/Fasebj.22.2_Supplement.545  0.422
2008 Cleare W, Casadevall A. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release 1 Medical Mycology. 37: 235-243. DOI: 10.1046/J.1365-280X.1999.00226.X  0.328
2008 DOERING T, NOSANCHUK JD, ROBERTS WK, CASADEVALL A. Melanin as a potential cryptococcal defence against microbicidal proteins Medical Mycology. 37: 175-181. DOI: 10.1046/J.1365-280X.1999.00218.X  0.315
2008 De Jesus M, Pirofski LA, Casadevall A. Carbohydrate-Based Antifungal Vaccines Carbohydrate-Based Vaccines and Immunotherapies. 215-226. DOI: 10.1002/9780470473283.ch7  0.515
2007 Frases S, Nimrichter L, Viana NB, Nakouzi A, Casadevall A. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryotic Cell. 7: 319-27. PMID 18156290 DOI: 10.1128/Ec.00378-07  0.341
2007 Torres M, Fernandez-Fuentes N, Fiser A, Casadevall A. Exchanging murine and human immunoglobulin constant chains affects the kinetics and thermodynamics of antigen binding and chimeric antibody autoreactivity. Plos One. 2: e1310. PMID 18074033 DOI: 10.1371/Journal.Pone.0001310  0.672
2007 Eisenman HC, Mues M, Weber SE, Frases S, Chaskes S, Gerfen G, Casadevall A. Cryptococcus neoformans laccase catalyses melanin synthesis from both D- and L-DOPA. Microbiology (Reading, England). 153: 3954-62. PMID 18048910 DOI: 10.1099/Mic.0.2007/011049-0  0.322
2007 Eisenman HC, Casadevall A, McClelland EE. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. Current Infectious Disease Reports. 9: 457-64. PMID 17999881 DOI: 10.1007/S11908-007-0070-8  0.334
2007 Casadevall A, Pirofski LA. Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes. Eukaryotic Cell. 6: 2169-74. PMID 17951515 DOI: 10.1128/Ec.00308-07  0.312
2007 Martinez LR, Ntiamoah P, Gácser A, Casadevall A, Nosanchuk JD. Voriconazole inhibits melanization in Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 51: 4396-400. PMID 17923488 DOI: 10.1128/Aac.00376-07  0.553
2007 Martinez LR, Ntiamoah P, Casadevall A, Nosanchuk JD. Caspofungin reduces the incidence of fungal contamination in cell culture. Mycopathologia. 164: 279-86. PMID 17899440 DOI: 10.1007/S11046-007-9063-2  0.561
2007 Al-Sayyed B, Piperdi S, Yuan X, Li A, Besra GS, Jacobs WR, Casadevall A, Glatman-Freedman A. Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51. Tuberculosis (Edinburgh, Scotland). 87: 489-97. PMID 17881291 DOI: 10.1016/J.Tube.2007.07.005  0.322
2007 Dadachova E, Bryan RA, Huang X, Ortiz G, Moadel T, Casadevall A. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5629s-5635s. PMID 17875799 DOI: 10.1158/1078-0432.Ccr-07-0870  0.378
2007 Casadevall A, Pirofski LA. Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infection and Immunity. 75: 5074-8. PMID 17709417 DOI: 10.1128/Iai.01001-07  0.424
2007 Alvarez M, Casadevall A. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. Bmc Immunology. 8: 16. PMID 17705844 DOI: 10.1186/1471-2172-8-16  0.658
2007 Mylonakis E, Casadevall A, Ausubel FM. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. Plos Pathogens. 3: e101. PMID 17676994 DOI: 10.1371/Journal.Ppat.0030101  0.358
2007 McFadden DC, Fries BC, Wang F, Casadevall A. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryotic Cell. 6: 1464-73. PMID 17601878 DOI: 10.1128/Ec.00162-07  0.33
2007 Nimrichter L, Frases S, Cinelli LP, Viana NB, Nakouzi A, Travassos LR, Casadevall A, Rodrigues ML. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Eukaryotic Cell. 6: 1400-10. PMID 17573547 DOI: 10.1128/Ec.00122-07  0.33
2007 Martinez LR, Casadevall A. Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Applied and Environmental Microbiology. 73: 4592-601. PMID 17513597 DOI: 10.1128/Aem.02506-06  0.556
2007 Casadevall A, Goldstein H, Dadachova E. Targeting host cells harbouring viruses with radiolabeled antibodies. Expert Opinion On Biological Therapy. 7: 595-7. PMID 17477798 DOI: 10.1517/14712598.7.5.595  0.371
2007 Zaragoza O, Alvarez M, Telzak A, Rivera J, Casadevall A. The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. Infection and Immunity. 75: 2729-39. PMID 17371865 DOI: 10.1128/Iai.00094-07  0.724
2007 De Jesus M, Hackett E, Durkin M, Connolly P, Casadevall A, Petraitiene R, Walsh TJ, Wheat LJ. Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay. Clinical and Vaccine Immunology : Cvi. 14: 624-7. PMID 17360857 DOI: 10.1128/Cvi.00368-06  0.595
2007 Torres M, Fernández-Fuentes N, Fiser A, Casadevall A. The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. The Journal of Biological Chemistry. 282: 13917-27. PMID 17353196 DOI: 10.1074/Jbc.M700661200  0.661
2007 Macura N, Zhang T, Casadevall A. Dependence of macrophage phagocytic efficacy on antibody concentration. Infection and Immunity. 75: 1904-15. PMID 17283107 DOI: 10.1128/Iai.01258-06  0.359
2007 Rodrigues ML, Nimrichter L, Oliveira DL, Frases S, Miranda K, Zaragoza O, Alvarez M, Nakouzi A, Feldmesser M, Casadevall A. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryotic Cell. 6: 48-59. PMID 17114598 DOI: 10.1128/Ec.00318-06  0.63
2007 Nosanchuk JD, Yu JJ, Hung CY, Casadevall A, Cole GT. Coccidioides posadasii produces melanin in vitro and during infection. Fungal Genetics and Biology : Fg & B. 44: 517-20. PMID 17074521 DOI: 10.1016/J.Fgb.2006.09.006  0.323
2007 Casadevall A. Determinants of virulence in the pathogenic fungi Fungal Biology Reviews. 21: 130-132. DOI: 10.1016/J.Fbr.2007.02.007  0.349
2006 Casadevall A, Pirofski LA. The weapon potential of human pathogenic fungi. Medical Mycology. 44: 689-96. PMID 17127625 DOI: 10.1080/13693780600928503  0.325
2006 Maxson ME, Dadachova E, Casadevall A, Zaragoza O. Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryotic Cell. 6: 95-109. PMID 17114596 DOI: 10.1128/Ec.00306-06  0.337
2006 Frases S, Salazar A, Dadachova E, Casadevall A. Cryptococcus neoformans can utilize the bacterial melanin precursor homogentisic acid for fungal melanogenesis. Applied and Environmental Microbiology. 73: 615-21. PMID 17098915 DOI: 10.1128/Aem.01947-06  0.334
2006 Dadachova E, Patel MC, Toussi S, Apostolidis C, Morgenstern A, Brechbiel MW, Gorny MK, Zolla-Pazner S, Casadevall A, Goldstein H. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. Plos Medicine. 3: e427. PMID 17090209 DOI: 10.1371/Journal.Pmed.0030427  0.326
2006 Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Current Biology : Cb. 16: 2161-5. PMID 17084702 DOI: 10.1016/J.Cub.2006.09.061  0.646
2006 Monari C, Kozel TR, Paganelli F, Pericolini E, Perito S, Bistoni F, Casadevall A, Vecchiarelli A. Microbial immune suppression mediated by direct engagement of inhibitory Fc receptor. Journal of Immunology (Baltimore, Md. : 1950). 177: 6842-51. PMID 17082598 DOI: 10.4049/Jimmunol.177.10.6842  0.306
2006 Martinez LR, Casadevall A. Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system. Infection and Immunity. 74: 6118-23. PMID 17057089 DOI: 10.1128/Iai.00995-06  0.582
2006 McFadden D, Zaragoza O, Casadevall A. The capsular dynamics of Cryptococcus neoformans. Trends in Microbiology. 14: 497-505. PMID 16996739 DOI: 10.1016/J.Tim.2006.09.003  0.329
2006 Casadevall A, Pirofski LA. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Advances in Immunology. 91: 1-44. PMID 16938537 DOI: 10.1016/S0065-2776(06)91001-3  0.408
2006 Pirofski LA, Casadevall A. Immunomodulators as an antimicrobial tool. Current Opinion in Microbiology. 9: 489-95. PMID 16931122 DOI: 10.1016/J.Mib.2006.08.004  0.34
2006 Mavrogiorgos N, Zaragoza O, Casadevall A, Nosanchuk JD. Efficacy of voriconazole in experimental Cryptococcus neoformans infection. Mycopathologia. 162: 111-4. PMID 16897589 DOI: 10.1007/S11046-006-0039-4  0.325
2006 Luo Y, Cook E, Fries BC, Casadevall A. Phagocytic efficacy of macrophage-like cells as a function of cell cycle and Fcgamma receptors (FcgammaR) and complement receptor (CR)3 expression. Clinical and Experimental Immunology. 145: 380-7. PMID 16879260 DOI: 10.1111/J.1365-2249.2006.03132.X  0.434
2006 Zaragoza O, Casadevall A. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance Cellular Microbiology. 8: 1862-1876. PMID 16824038 DOI: 10.1111/J.1462-5822.2006.00753.X  0.392
2006 Rivera J, Nakouzi A, Abboud N, Revskaya E, Goldman D, Collier RJ, Dadachova E, Casadevall A. A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1. Infection and Immunity. 74: 4149-56. PMID 16790789 DOI: 10.1128/Iai.00150-06  0.732
2006 Martinez LR, Christaki E, Casadevall A. Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro. The Journal of Infectious Diseases. 194: 261-6. PMID 16779734 DOI: 10.1086/504722  0.578
2006 Li L, Zaragoza O, Casadevall A, Fries BC. Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis. Cellular Microbiology. 8: 1730-9. PMID 16759224 DOI: 10.1111/J.1462-5822.2006.00742.X  0.382
2006 Martinez LR, Bryan RA, Apostolidis C, Morgenstern A, Casadevall A, Dadachova E. Antibody-guided alpha radiation effectively damages fungal biofilms. Antimicrobial Agents and Chemotherapy. 50: 2132-6. PMID 16723575 DOI: 10.1128/Aac.00120-06  0.57
2006 Dadachova E, Bryan RA, Apostolidis C, Morgenstern A, Zhang T, Moadel T, Torres M, Huang X, Revskaya E, Casadevall A. Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection. The Journal of Infectious Diseases. 193: 1427-36. PMID 16619191 DOI: 10.1086/503369  0.68
2006 Casadevall A. The third age of antimicrobial therapy Clinical Infectious Diseases. 42: 1414-1416. PMID 16619153 DOI: 10.1086/503431  0.305
2006 Goldman DL, Davis J, Bommarito F, Shao X, Casadevall A. Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma. The Journal of Infectious Diseases. 193: 1178-86. PMID 16544260 DOI: 10.1086/501363  0.315
2006 McClelland EE, Bernhardt P, Casadevall A. Estimating the relative contributions of virulence factors for pathogenic microbes. Infection and Immunity. 74: 1500-4. PMID 16495520 DOI: 10.1128/Iai.74.3.1500-1504.2006  0.317
2006 Martinez LR, Casadevall A. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrobial Agents and Chemotherapy. 50: 1021-33. PMID 16495265 DOI: 10.1128/Aac.50.3.1021-1033.2006  0.574
2006 Frases S, Chaskes S, Dadachova E, Casadevall A. Induction by Klebsiella aerogenes of a melanin-like pigment in Cryptococcus neoformans. Applied and Environmental Microbiology. 72: 1542-50. PMID 16461709 DOI: 10.1128/Aem.72.2.1542-1550.2006  0.341
2006 Pericolini E, Cenci E, Monari C, De Jesus M, Bistoni F, Casadevall A, Vecchiarelli A. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8. Cellular Microbiology. 8: 267-75. PMID 16441437 DOI: 10.1111/J.1462-5822.2005.00619.X  0.641
2006 Zaragoza O, Telzak A, Bryan RA, Dadachova E, Casadevall A. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Molecular Microbiology. 59: 67-83. PMID 16359319 DOI: 10.1111/J.1365-2958.2005.04928.X  0.35
2006 Casadevall A, Pirofski LA. Polysaccharide-containing conjugate vaccines for fungal diseases. Trends in Molecular Medicine. 12: 6-9. PMID 16309965 DOI: 10.1016/J.Molmed.2005.11.003  0.314
2006 McFadden DC, De Jesus M, Casadevall A. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction. The Journal of Biological Chemistry. 281: 1868-75. PMID 16278213 DOI: 10.1074/Jbc.M509465200  0.628
2006 Zaragoza O, Mihu C, Casadevall A, Nosanchuk JD. Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection. Antimicrobial Agents and Chemotherapy. 49: 4358-61. PMID 16189121 DOI: 10.1128/Aac.49.10.4358-4361.2005  0.341
2006 Wang F, Nakouzi A, Alvarez M, Zaragoza O, Angeletti RH, Casadevall A. Structural and functional characterization of glycosylation in an immunoglobulin G1 to Cryptococcus neoformans glucuronoxylomannan. Molecular Immunology. 43: 987-98. PMID 16045988 DOI: 10.1016/J.Molimm.2005.05.013  0.665
2005 McClelland EE, Bernhardt P, Casadevall A. Coping with multiple virulence factors: which is most important? Plos Pathogens. 1: e40. PMID 16738705 DOI: 10.1371/Journal.Ppat.0010040  0.332
2005 Casadevall A, Pirofski LA. Feasibility and prospects for a vaccine to prevent cryptococcosis. Medical Mycology. 43: 667-80. PMID 16422296 DOI: 10.1080/13693780500448230  0.3
2005 Dadachova E, Casadevall A. Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases Expert Opinion On Drug Delivery. 2: 1075-1084. PMID 16296810 DOI: 10.1517/17425247.2.6.1075  0.319
2005 Jain N, Wickes BL, Keller SM, Fu J, Casadevall A, Jain P, Ragan MA, Banerjee U, Fries BC. Molecular epidemiology of clinical Cryptococcus neoformans strains from India. Journal of Clinical Microbiology. 43: 5733-42. PMID 16272511 DOI: 10.1128/Jcm.43.11.5733-5742.2005  0.32
2005 Shao X, Rivera J, Niang R, Casadevall A, Goldman DL. A dual role for TGF-beta1 in the control and persistence of fungal pneumonia. Journal of Immunology (Baltimore, Md. : 1950). 175: 6757-63. PMID 16272332 DOI: 10.4049/Jimmunol.175.10.6757  0.534
2005 da Silva MB, Marques AF, Nosanchuk JD, Casadevall A, Travassos LR, Taborda CP. Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility. Microbes and Infection. 8: 197-205. PMID 16213179 DOI: 10.1016/J.Micinf.2005.06.018  0.35
2005 Casadevall A, Pirofski LA. The potential of antibody-mediated immunity in the defence against biological weapons. Expert Opinion On Biological Therapy. 5: 1359-72. PMID 16197341 DOI: 10.1517/14712598.5.10.1359  0.355
2005 Martinez LR, Casadevall A. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infection and Immunity. 73: 6350-62. PMID 16177306 DOI: 10.1128/Iai.73.10.6350-6362.2005  0.605
2005 Mandal P, Banerjee U, Casadevall A, Nosanchuk JD. Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India. Journal of Clinical Microbiology. 43: 4766-72. PMID 16145139 DOI: 10.1128/Jcm.43.9.4766-4772.2005  0.373
2005 Shao X, Mednick A, Alvarez M, van Rooijen N, Casadevall A, Goldman DL. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. Journal of Immunology (Baltimore, Md. : 1950). 175: 3244-51. PMID 16116215 DOI: 10.4049/Jimmunol.175.5.3244  0.655
2005 Morris-Jones R, Gomez BL, Diez S, Uran M, Morris-Jones SD, Casadevall A, Nosanchuk JD, Hamilton AJ. Synthesis of melanin pigment by Candida albicans in vitro and during infection. Infection and Immunity. 73: 6147-50. PMID 16113337 DOI: 10.1128/Iai.73.9.6147-6150.2005  0.326
2005 Casadevall A, Pirofski L. Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans Current Molecular Medicine. 5: 421-433. PMID 15977998 DOI: 10.2174/1566524054022567  0.436
2005 Casadevall A. Host as the variable: Model hosts approach the immunological asymptote Infection and Immunity. 73: 3829-3832. PMID 15972467 DOI: 10.1128/Iai.73.7.3829-3832.2005  0.312
2005 Rivera J, Casadevall A. Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans. Journal of Immunology (Baltimore, Md. : 1950). 174: 8017-26. PMID 15944309 DOI: 10.4049/Jimmunol.174.12.8017  0.555
2005 Oscarson S, Alpe M, Svahnberg P, Nakouzi A, Casadevall A. Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures. Vaccine. 23: 3961-72. PMID 15917118 DOI: 10.1016/J.Vaccine.2005.02.029  0.364
2005 Luo Y, Tucker SC, Casadevall A. Fc- and complement-receptor activation stimulates cell cycle progression of macrophage cells from G1 to S. Journal of Immunology (Baltimore, Md. : 1950). 174: 7226-33. PMID 15905568 DOI: 10.4049/Jimmunol.174.11.7226  0.498
2005 Garcia-Rivera J, Tucker SC, Feldmesser M, Williamson PR, Casadevall A. Laccase expression in murine pulmonary Cryptococcus neoformans infection. Infection and Immunity. 73: 3124-7. PMID 15845520 DOI: 10.1128/Iai.73.5.3124-3127.2005  0.318
2005 McLean GR, Torres M, Trotter B, Noseda M, Bryson S, Pai EF, Schrader JW, Casadevall A. A point mutation in the Ch3 domain of human IgG3 inhibits antibody secretion without affecting antigen specificity. Molecular Immunology. 42: 1111-9. PMID 15829300 DOI: 10.1016/J.Molimm.2004.11.015  0.621
2005 Mednick AJ, Nosanchuk JD, Casadevall A. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infection and Immunity. 73: 2012-9. PMID 15784542 DOI: 10.1128/Iai.73.4.2012-2019.2005  0.399
2005 Eisenman HC, Nosanchuk JD, Webber JB, Emerson RJ, Camesano TA, Casadevall A. Microstructure of cell wall-associated melanin in the human pathogenic fungus Cryptococcus neoformans. Biochemistry. 44: 3683-93. PMID 15751945 DOI: 10.1021/Bi047731M  0.319
2005 Monari C, Pericolini E, Bistoni G, Casadevall A, Kozel TR, Vecchiarelli A. Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages. Journal of Immunology (Baltimore, Md. : 1950). 174: 3461-8. PMID 15749881 DOI: 10.4049/Jimmunol.174.6.3461  0.324
2005 Fries BC, Lee SC, Kennan R, Zhao W, Casadevall A, Goldman DL. Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infection and Immunity. 73: 1779-87. PMID 15731079 DOI: 10.1128/Iai.73.3.1779-1787.2005  0.303
2005 Bryan RA, Zaragoza O, Zhang T, Ortiz G, Casadevall A, Dadachova E. Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryotic Cell. 4: 465-75. PMID 15701808 DOI: 10.1128/Ec.4.2.465-475.2005  0.353
2005 Torres M, May R, Scharff MD, Casadevall A. Variable-region-identical antibodies differing in isotype demonstrate differences in fine specificity and idiotype. Journal of Immunology (Baltimore, Md. : 1950). 174: 2132-42. PMID 15699144 DOI: 10.4049/Jimmunol.174.4.2132  0.636
2005 Casadevall A. Fungal virulence, vertebrate endothermy, and dinosaur extinction: Is there a connection? Fungal Genetics and Biology. 42: 98-106. PMID 15670708 DOI: 10.1016/J.Fgb.2004.11.008  0.331
2005 Rivera J, Zaragoza O, Casadevall A. Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infection and Immunity. 73: 1141-50. PMID 15664957 DOI: 10.1128/Iai.73.2.1141-1150.2005  0.572
2005 Fries BC, Cook E, Wang X, Casadevall A. Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 49: 350-7. PMID 15616315 DOI: 10.1128/Aac.49.1.350-357.2005  0.349
2004 Casadevall A, Pirofski LA. New concepts in antibody-mediated immunity. Infection and Immunity. 72: 6191-6. PMID 15501743 DOI: 10.1128/Iai.72.11.6191-6196.2004  0.389
2004 Nosanchuk JD, van Duin D, Mandal P, Aisen P, Legendre AM, Casadevall A. Blastomyces dermatitidis produces melanin in vitro and during infection. Fems Microbiology Letters. 239: 187-93. PMID 15451118 DOI: 10.1016/J.Femsle.2004.08.040  0.37
2004 Casadevall A, Dadachova E, Pirofski LA. Passive antibody therapy for infectious diseases. Nature Reviews. Microbiology. 2: 695-703. PMID 15372080 DOI: 10.1038/Nrmicro974  0.335
2004 Casadevall A. The methodology for determining the efficacy of antibody-mediated immunity Journal of Immunological Methods. 291: 1-10. PMID 15345300 DOI: 10.1016/J.Jim.2004.04.027  0.376
2004 Morris-Jones R, Youngchim S, Hextall JM, Gomez BL, Morris-Jones SD, Hay RJ, Casadevall A, Nosanchuk JD, Hamilton AJ. Scytalidium dimidiatum causing recalcitrant subcutaneous lesions produces melanin. Journal of Clinical Microbiology. 42: 3789-94. PMID 15297531 DOI: 10.1128/Jcm.42.8.3789-3794.2004  0.307
2004 Glatman-Freedman A, Casadevall A, Dai Z, Jacobs WR, Li A, Morris SL, Navoa JA, Piperdi S, Robbins JB, Schneerson R, Schwebach JR, Shapiro M. Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. Journal of Clinical Microbiology. 42: 3225-31. PMID 15243086 DOI: 10.1128/Jcm.42.7.3225-3231.2004  0.343
2004 Zaragoza O, Casadevall A. Antibodies produced in response to Cryptococcus neoformans pulmonary infection in mice have characteristics of nonprotective antibodies Infection and Immunity. 72: 4271-4274. PMID 15213172 DOI: 10.1128/Iai.72.7.4271-4274.2004  0.41
2004 McFadden DC, Zaragoza O, Casadevall A. Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum. Journal of Clinical Microbiology. 42: 2786-8. PMID 15184471 DOI: 10.1128/Jcm.42.6.2786-2788.2004  0.332
2004 Casadevall A, Pirofski LA. The weapon potential of a microbe. Trends in Microbiology. 12: 259-63. PMID 15165603 DOI: 10.1016/J.Tim.2004.04.007  0.304
2004 Martinez LR, Moussai D, Casadevall A. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen. Infection and Immunity. 72: 3674-9. PMID 15155683 DOI: 10.1128/Iai.72.6.3674-3679.2004  0.579
2004 Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A. Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii. Infection and Immunity. 72: 3478-88. PMID 15155655 DOI: 10.1128/Iai.72.6.3478-3488.2004  0.705
2004 van Duin D, Cleare W, Zaragoza O, Casadevall A, Nosanchuk JD. Effects of voriconazole on Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 48: 2014-20. PMID 15155193 DOI: 10.1128/Aac.48.6.2014-2020.2004  0.33
2004 Malliaris SD, Steenbergen JN, Casadevall A. Cryptococcus neoformans var. gattii can exploit Acanthamoeba castellanii for growth. Medical Mycology. 42: 149-58. PMID 15124868 DOI: 10.1080/13693786310001616500  0.717
2004 Dadachova E, Burns T, Bryan RA, Apostolidis C, Brechbiel MW, Nosanchuk JD, Casadevall A, Pirofski L. Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrobial Agents and Chemotherapy. 48: 1624-9. PMID 15105113 DOI: 10.1128/Aac.48.5.1624-1629.2004  0.403
2004 García-Rivera J, Chang YC, Kwon-Chung KJ, Casadevall A. Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryotic Cell. 3: 385-92. PMID 15075268 DOI: 10.1128/Ec.3.2.385-392.2004  0.331
2004 McFadden DC, Casadevall A. Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans. Journal of Immunology (Baltimore, Md. : 1950). 172: 3670-7. PMID 15004170 DOI: 10.4049/Jimmunol.172.6.3670  0.333
2004 Dadachova E, Bryan RA, Frenkel A, Zhang T, Apostolidis C, Nosanchuk JS, Nosanchuk JD, Casadevall A. Evaluation of acute hematologic and long-term pulmonary toxicities of radioimmunotherapy of Cryptococcus neoformans infection in murine models. Antimicrobial Agents and Chemotherapy. 48: 1004-6. PMID 14982795 DOI: 10.1128/Aac.48.3.1004-1006.2004  0.315
2004 Pirofski L, Casadevall A. Response to Fehr and Ochsenbein: ‘Good’, ‘bad’ and ‘neutral’ antibodies depend on the host–microbe interaction Trends in Immunology. 25: 167-168. DOI: 10.1016/J.It.2004.02.005  0.32
2003 Casadevall A, Pirofski LA. The damage-response framework of microbial pathogenesis. Nature Reviews. Microbiology. 1: 17-24. PMID 15040176 DOI: 10.1038/Nrmicro732  0.315
2003 Zaragoza O, Fries BC, Casadevall A. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infection and Immunity. 71: 6155-64. PMID 14573631 DOI: 10.1128/Iai.71.11.6155-6164.2003  0.308
2003 Nosanchuk JD, Steenbergen JN, Shi L, Deepe GS, Casadevall A. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. The Journal of Clinical Investigation. 112: 1164-75. PMID 14561701 DOI: 10.1172/Jci19361  0.733
2003 Nakouzi A, Casadevall A. The function of conserved amino acids in or near the complementarity determining regions for related antibodies to Cryptococcus neoformans glucuronoxylomannan Molecular Immunology. 40: 351-361. PMID 14522016 DOI: 10.1016/S0161-5890(03)00149-4  0.309
2003 Casadevall A, Pirofski LA. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends in Immunology. 24: 474-8. PMID 12967670 DOI: 10.1016/S1471-4906(03)00228-X  0.396
2003 Vecchiarelli A, Pietrella D, Lupo P, Bistoni F, McFadden DC, Casadevall A. The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. Journal of Leukocyte Biology. 74: 370-8. PMID 12949240 DOI: 10.1189/Jlb.1002476  0.308
2003 Casadevall A, Steenbergen JN, Nosanchuk JD. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm. Current Opinion in Microbiology. 6: 332-7. PMID 12941400 DOI: 10.1016/S1369-5274(03)00082-1  0.695
2003 Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infection and Immunity. 71: 4862-72. PMID 12933827 DOI: 10.1128/Iai.71.9.4862-4872.2003  0.726
2003 Dadachova E, Nakouzi A, Bryan RA, Casadevall A. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proceedings of the National Academy of Sciences of the United States of America. 100: 10942-7. PMID 12930899 DOI: 10.1073/Pnas.1731272100  0.39
2003 Zaragoza O, Taborda CP, Casadevall A. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. European Journal of Immunology. 33: 1957-67. PMID 12884862 DOI: 10.1002/Eji.200323848  0.417
2003 Casadevall A. Antibody-mediated immunity against intracellular pathogens: Two-dimensional thinking comes full circle Infection and Immunity. 71: 4225-4228. PMID 12874297 DOI: 10.1128/Iai.71.8.4225-4228.2003  0.395
2003 Pietrella D, Fries B, Lupo P, Bistoni F, Casadevall A, Vecchiarelli A. Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response. Cellular Microbiology. 5: 513-22. PMID 12864811 DOI: 10.1046/J.1462-5822.2003.00297.X  0.343
2003 Nosanchuk JD, Casadevall A. Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa Microbiology. 149: 1945-1951. PMID 12855745 DOI: 10.1099/Mic.0.26333-0  0.309
2003 Morris-Jones R, Youngchim S, Gomez BL, Aisen P, Hay RJ, Nosanchuk JD, Casadevall A, Hamilton AJ. Synthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infection and Immunity. 71: 4026-33. PMID 12819091 DOI: 10.1128/Iai.71.7.4026-4033.2003  0.381
2003 Steenbergen JN, Casadevall A. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes and Infection / Institut Pasteur. 5: 667-75. PMID 12787743 DOI: 10.1016/S1286-4579(03)00092-3  0.69
2003 Casadevall A, Pirofski LA. Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity. The Journal of Experimental Medicine. 197: 1401-4. PMID 12782708 DOI: 10.1084/Jem.20030637  0.309
2003 Mednick AJ, Feldmesser M, Rivera J, Casadevall A. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. European Journal of Immunology. 33: 1744-53. PMID 12778493 DOI: 10.1002/Eji.200323626  0.547
2003 Nosanchuk JD, Casadevall A. The contribution of melanin to microbial pathogenesis Cellular Microbiology. 5: 203-223. PMID 12675679 DOI: 10.1046/J.1462-5814.2003.00268.X  0.404
2003 Monari C, Retini C, Casadevall A, Netski D, Bistoni F, Kozel TR, Vecchiarelli A. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. European Journal of Immunology. 33: 1041-51. PMID 12672070 DOI: 10.1002/Eji.200323388  0.373
2003 Taborda CP, Rivera J, Zaragoza O, Casadevall A. More is not necessarily better: prozone-like effects in passive immunization with IgG. Journal of Immunology (Baltimore, Md. : 1950). 170: 3621-30. PMID 12646626 DOI: 10.4049/Jimmunol.170.7.3621  0.576
2003 He W, Casadevall A, Lee SC, Goldman DL. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis. Infection and Immunity. 71: 930-6. PMID 12540575 DOI: 10.1128/Iai.71.2.930-936.2003  0.375
2003 Navoa JA, Laal S, Pirofski LA, McLean GR, Dai Z, Robbins JB, Schneerson R, Casadevall A, Glatman-Freedman A. Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. Clinical and Diagnostic Laboratory Immunology. 10: 88-94. PMID 12522045 DOI: 10.1128/Cdli.10.1.88-94.2003  0.359
2003 Cox GM, Harrison TS, McDade HC, Taborda CP, Heinrich G, Casadevall A, Perfect JR. Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophages. Infection and Immunity. 71: 173-80. PMID 12496163 DOI: 10.1128/Iai.71.1.173-180.2003  0.327
2003 van Duin D, Casadevall A, Nosanchuk JD. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrobial Agents and Chemotherapy. 46: 3394-400. PMID 12384341 DOI: 10.1128/Aac.46.11.3394-3400.2002  0.358
2002 Fries BC, Goldman DL, Casadevall A. Phenotypic switching in Cryptococcus neoformans. Microbes and Infection / Institut Pasteur. 4: 1345-52. PMID 12443899 DOI: 10.1016/S1286-4579(02)00006-0  0.321
2002 Pirofski LA, Casadevall A. The meaning of microbial exposure, infection, colonisation, and disease in clinical practice. The Lancet. Infectious Diseases. 2: 628-35. PMID 12383613 DOI: 10.1016/S1473-3099(02)00398-5  0.321
2002 Song X, Shapiro S, Goldman DL, Casadevall A, Scharff M, Lee SC. Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia. Infection and Immunity. 70: 5177-84. PMID 12183568 DOI: 10.1128/Iai.70.9.5177-5184.2002  0.312
2002 Nosanchuk JD, Gómez BL, Youngchim S, Díez S, Aisen P, Zancopé-Oliveira RM, Restrepo A, Casadevall A, Hamilton AJ. Histoplasma capsulatum synthesizes melanin-like pigments in vitro and during mammalian infection. Infection and Immunity. 70: 5124-31. PMID 12183562 DOI: 10.1128/Iai.70.9.5124-5131.2002  0.386
2002 Casadevall A, Feldmesser M, Pirofski LA. Induced humoral immunity and vaccination against major human fungal pathogens. Current Opinion in Microbiology. 5: 386-91. PMID 12160857 DOI: 10.1016/S1369-5274(02)00337-5  0.382
2002 Casadevall A. Passive antibody administration (immediate immunity) as a specific defense against biological weapons Emerging Infectious Diseases. 8: 833-841. PMID 12141970 DOI: 10.3201/Eid0808.010516  0.375
2002 McLean GR, Torres M, Elguezabal N, Nakouzi A, Casadevall A. Isotype can affect the fine specificity of an antibody for a polysaccharide antigen. Journal of Immunology (Baltimore, Md. : 1950). 169: 1379-86. PMID 12133962 DOI: 10.4049/Jimmunol.169.3.1379  0.657
2002 Vecchiarelli A, Pietrella D, Bistoni F, Kozel TR, Casadevall A. Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells. Immunology. 106: 267-72. PMID 12047756 DOI: 10.1046/J.1365-2567.2002.01419.X  0.35
2002 Casadevall A, Pirofski LA. What is a pathogen? Annals of Medicine. 34: 2-4. PMID 12014430 DOI: 10.1080/078538902317338580  0.312
2002 Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC, Casadevall A, Scharff MD. Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infection and Immunity. 70: 2598-604. PMID 11953401 DOI: 10.1128/Iai.70.5.2598-2604.2002  0.391
2002 Rivera J, Mukherjee J, Weiss LM, Casadevall A. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. Journal of Immunology (Baltimore, Md. : 1950). 168: 3419-27. PMID 11907100 DOI: 10.4049/Jimmunol.168.7.3419  0.532
2002 Tucker SC, Casadevall A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proceedings of the National Academy of Sciences of the United States of America. 99: 3165-70. PMID 11880650 DOI: 10.1073/Pnas.052702799  0.375
2002 Feldmesser M, Mednick A, Casadevall A. Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses. Infection and Immunity. 70: 1571-80. PMID 11854246 DOI: 10.1128/Iai.70.3.1571-1580.2002  0.403
2002 Casadevall A. Antibodies for defense against biological attack Nature Biotechnology. 20: 114. PMID 11821846 DOI: 10.1038/Nbt0202-114  0.327
2002 Westin Kwon K, Lendvai N, Morrison S, Trinh KR, Casadevall A. Biological activity of a mouse-human chimeric immunoglobulin G2 antibody to Cryptococcus neoformans polysaccharide. Clinical and Diagnostic Laboratory Immunology. 9: 201-4. PMID 11777857 DOI: 10.1128/Cdli.9.1.201-204.2002  0.678
2002 Rosas AL, MacGill RS, Nosanchuk JD, Kozel TR, Casadevall A. Activation of the alternative complement pathway by fungal melanins. Clinical and Diagnostic Laboratory Immunology. 9: 144-8. PMID 11777844 DOI: 10.1128/Cdli.9.1.144-148.2002  0.777
2002 Fries BC, Taborda CP, Serfass E, Casadevall A. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. The Journal of Clinical Investigation. 108: 1639-48. PMID 11733559 DOI: 10.1172/Jci13407  0.329
2001 McFadden DC, Casadevall A. Capsule and melanin synthesis in Cryptococcus neoformans. Medical Mycology. 39: 19-30. PMID 11800266 DOI: 10.1080/Mmy.39.1.19.30  0.341
2001 Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proceedings of the National Academy of Sciences of the United States of America. 98: 15245-50. PMID 11742090 DOI: 10.1073/Pnas.261418798  0.715
2001 García-Rivera J, Casadevall A. Melanization of Cryptococcus neoformans reduces its susceptibility to the antimicrobial effects of silver nitrate. Medical Mycology. 39: 353-7. PMID 11556765 DOI: 10.1080/Mmy.39.4.353.357  0.343
2001 Rosas AL, Casadevall A. Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation. Mycopathologia. 151: 53-6. PMID 11554578 DOI: 10.1023/A:1010977107089  0.74
2001 Beenhouwer DO, Shapiro S, Feldmesser M, Casadevall A, Scharff MD. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Infection and Immunity. 69: 6445-55. PMID 11553589 DOI: 10.1128/Iai.69.10.6445-6455.2001  0.342
2001 Casadevall A, Pirofski LA. Adjunctive immune therapy for fungal infections Clinical Infectious Diseases. 33: 1048-1056. PMID 11528579 DOI: 10.1086/322710  0.359
2001 Martinez LR, Garcia-Rivera J, Casadevall A. Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C. neoformans var. grubii (serotype A) strains. Journal of Clinical Microbiology. 39: 3365-7. PMID 11526180 DOI: 10.1128/Jcm.39.9.3365-3367.2001  0.534
2001 Gómez BL, Nosanchuk JD, Díez S, Youngchim S, Aisen P, Cano LE, Restrepo A, Casadevall A, Hamilton AJ. Detection of melanin-like pigments in the dimorphic fungal pathogen Paracoccidioides brasiliensis in vitro and during infection. Infection and Immunity. 69: 5760-7. PMID 11500453 DOI: 10.1128/Iai.69.9.5760-5767.2001  0.356
2001 Schwebach JR, Casadevall A, Schneerson R, Dai Z, Wang X, Robbins JB, Glatman-Freedman A. Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infection and Immunity. 69: 5671-8. PMID 11500443 DOI: 10.1128/Iai.69.9.5671-5678.2001  0.34
2001 Zhu X, Gibbons J, Garcia-Rivera J, Casadevall A, Williamson PR. Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infection and Immunity. 69: 5589-96. PMID 11500433 DOI: 10.1128/Iai.69.9.5589-5596.2001  0.388
2001 Feldmesser M, Kress Y, Casadevall A. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology (Reading, England). 147: 2355-2365. PMID 11496012 DOI: 10.1099/00221287-147-8-2355  0.378
2001 Casadevall A, Pirofski LA. Host-pathogen interactions: The attributes of virulence Journal of Infectious Diseases. 184: 337-344. PMID 11443560 DOI: 10.1086/322044  0.324
2001 Feldmesser M, Tucker S, Casadevall A. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends in Microbiology. 9: 273-8. PMID 11390242 DOI: 10.1016/S0966-842X(01)02035-2  0.411
2001 Wills EA, Roberts IS, Del Poeta M, Rivera J, Casadevall A, Cox GM, Perfect JR. Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase-encoding gene, MAN1, and its impact on pathogenicity. Molecular Microbiology. 40: 610-20. PMID 11359567 DOI: 10.1046/J.1365-2958.2001.02401.X  0.552
2001 Goldman DL, Khine H, Abadi J, Lindenberg DJ, Niang R, Casadevall A. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics. 107: E66. PMID 11331716 DOI: 10.1542/Peds.107.5.E66  0.309
2001 Rosas AL, Nosanchuk JD, Casadevall A. Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infection and Immunity. 69: 3410-2. PMID 11292764 DOI: 10.1128/Iai.69.5.3410-3412.2001  0.783
2001 Nakouzi A, Valadon P, Nosanchuk J, Green N, Casadevall A. Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies. Infection and Immunity. 69: 3398-409. PMID 11292763 DOI: 10.1128/Iai.69.5.3398-3409.2001  0.325
2001 Feldmesser M, Kress Y, Casadevall A. Intracellular crystal formation as a mechanism of cytotoxicity in murine pulmonary Cryptococcus neoformans infection. Infection and Immunity. 69: 2723-7. PMID 11254641 DOI: 10.1128/Iai.69.4.2723-2727.2001  0.311
2001 Nosanchuk JD, Ovalle R, Casadevall A. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. The Journal of Infectious Diseases. 183: 1093-9. PMID 11237835 DOI: 10.1086/319272  0.365
2001 Goldman D, Song X, Kitai R, Casadevall A, Zhao ML, Lee SC. Cryptococcus neoformans induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta in human microglia: role of specific antibody and soluble capsular polysaccharide. Infection and Immunity. 69: 1808-15. PMID 11179358 DOI: 10.1128/Iai.69.3.1808-1815.2001  0.329
2001 Taborda CP, Casadevall A. Immunoglobulin M efficacy against Cryptococcus neoformans: Mechanism, dose dependence, and prozone-like effects in passive protection experiments Journal of Immunology. 166: 2100-2107. PMID 11160261 DOI: 10.4049/Jimmunol.166.3.2100  0.381
2001 Luberto C, Toffaletti DL, Wills EA, Tucker SC, Casadevall A, Perfect JR, Hannun YA, Del Poeta M. Roles for Inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans Genes and Development. 15: 201-212. PMID 11157776 DOI: 10.1101/Gad.856001  0.361
2001 Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, Wright LC, Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA, Perfect JR. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Molecular Microbiology. 39: 166-75. PMID 11123698 DOI: 10.1046/J.1365-2958.2001.02236.X  0.325
2001 Feldmesser M, Tucker S, Casadevall A. Cryptococcus neoformans: intracellular or extracellular? Trends in Microbiology. 9: 418. DOI: 10.1016/S0966-842X(01)02138-2  0.437
2000 San-Blas G, Travassos LR, Fries BC, Goldman DL, Casadevall A, Carmona AK, Barros TF, Puccia R, Hostetter MK, Shanks SG, Copping VM, Knox Y, Gow NA. Fungal morphogenesis and virulence. Medical Mycology. 38: 79-86. PMID 11204167 DOI: 10.1080/Mmy.38.S1.79.86  0.352
2000 Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, et al. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Medical Mycology. 38: 281-92. PMID 11204156 DOI: 10.1080/Mmy.38.S1.281.292  0.44
2000 Heitman J, Casadevall A, Lodge JK, Perfect JR. The Cryptococcus neoformans genome sequencing project. Mycopathologia. 148: 1-7. PMID 11086479 DOI: 10.1023/A:1007136602930  0.313
2000 Casadevall A, Pirofski LA. Host-pathogen interactions: Basic concepts of microbial commensalism, colonization, infection, and disease Infection and Immunity. 68: 6511-6518. PMID 11083759 DOI: 10.1128/Iai.68.12.6511-6518.2000  0.324
2000 Feldmesser M, Kress Y, Mednick A, Casadevall A. The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. The Journal of Infectious Diseases. 182: 1791-5. PMID 11069257 DOI: 10.1086/317614  0.305
2000 Rosas AL, Nosanchuk JD, Gómez BL, Edens WA, Henson JM, Casadevall A. Isolation and serological analyses of fungal melanins. Journal of Immunological Methods. 244: 69-80. PMID 11033020 DOI: 10.1016/S0022-1759(00)00255-6  0.744
2000 Casadevall A, Rosas AL, Nosanchuk JD. Melanin and virulence in Cryptococcus neoformans. Current Opinion in Microbiology. 3: 354-8. PMID 10972493 DOI: 10.1016/S1369-5274(00)00103-X  0.776
2000 Mozaffarian N, Casadevall A, Berman JW. Inhibition of human endothelial cell chemokine production by the opportunistic fungal pathogen Cryptococcus neoformans. Journal of Immunology (Baltimore, Md. : 1950). 165: 1541-7. PMID 10903762 DOI: 10.4049/Jimmunol.165.3.1541  0.782
2000 Nosanchuk JD, Rosas AL, Lee SC, Casadevall A. Melanisation of Cryptococcus neoformans in human brain tissue. Lancet (London, England). 355: 2049-50. PMID 10885360 DOI: 10.1016/S0140-6736(00)02356-4  0.723
2000 Feldmesser M, Rivera J, Kress Y, Kozel TR, Casadevall A. Antibody interactions with the capsule of Cryptococcus neoformans. Infection and Immunity. 68: 3642-50. PMID 10816523 DOI: 10.1128/Iai.68.6.3642-3650.2000  0.551
2000 Steenbergen JN, Casadevall A. Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City. Journal of Clinical Microbiology. 38: 1974-6. PMID 10790132 DOI: 10.1128/Jcm.38.5.1974-1976.2000  0.636
2000 MacGill TC, MacGill RS, Casadevall A, Kozel TR. Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans Journal of Immunology. 164: 4835-4842. PMID 10779792 DOI: 10.4049/Jimmunol.164.9.4835  0.327
2000 Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infection and Immunity. 68: 2845-53. PMID 10768981 DOI: 10.1128/Iai.68.5.2845-2853.2000  0.766
2000 Lendvai N, Qu XW, Hsueh W, Casadevall A. Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. Journal of Immunology (Baltimore, Md. : 1950). 164: 4367-74. PMID 10754337 DOI: 10.4049/Jimmunol.164.8.4367  0.7
2000 Goldman DL, Lee SC, Mednick AJ, Montella L, Casadevall A. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infection and Immunity. 68: 832-8. PMID 10639453 DOI: 10.1128/Iai.68.2.832-838.2000  0.387
2000 Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR. Urease as a virulence factor in experimental cryptococcosis. Infection and Immunity. 68: 443-8. PMID 10639402 DOI: 10.1128/Iai.68.2.443-448.2000  0.355
2000 Glatman-Freedman A, Mednick AJ, Lendvai N, Casadevall A. Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M. Infection and Immunity. 68: 335-41. PMID 10603406 DOI: 10.1128/Iai.68.1.335-341.2000  0.678
2000 Steenbergen JN, Casadevall A. Prevalence of Cryptococcus neoformansvar. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) Isolates in New York City Journal of Clinical Microbiology. 38: 1974-1976. DOI: 10.1128/jcm.38.5.1974-1976.2000  0.607
2000 Stevens DA, Kullberg BJ, Brummer E, Casadevall A, Netea MG, Sugar AM. Combined treatment: antifungal drugs with antibodies, cytokines or drugs Medical Mycology. 38: 305-315. DOI: 10.1080/Mmy.38.S1.305.315  0.354
1999 Fries BC, Goldman DL, Cherniak R, Ju R, Casadevall A. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infection and Immunity. 67: 6076-83. PMID 10531269 DOI: 10.1128/Iai.67.11.6076-6083.1999  0.323
1999 Casadevall A. Passive antibody therapies: Progress and continuing challenges Clinical Immunology. 93: 5-15. PMID 10497006 DOI: 10.1006/Clim.1999.4768  0.319
1999 Nosanchuk JD, Rudolph J, Rosas AL, Casadevall A. Evidence that Cryptococcus neoformans is melanized in pigeon excreta: implications for pathogenesis. Infection and Immunity. 67: 5477-9. PMID 10496933 DOI: 10.1128/Iai.67.10.5477-5479.1999  0.753
1999 Monari C, Kozel TR, Casadevall A, Pietrella D, Palazzetti B, Vecchiarelli A. B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans Immunology. 98: 27-35. PMID 10469230 DOI: 10.1046/J.1365-2567.1999.00853.X  0.33
1999 Nussbaum G, Anandasabapathy S, Mukherjee J, Fan M, Casadevall A, Scharff MD. Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice. Infection and Immunity. 67: 4469-76. PMID 10456888 DOI: 10.1128/Iai.67.9.4469-4476.1999  0.362
1999 Lendvai N, Casadevall A. Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype. The Journal of Infectious Diseases. 180: 791-801. PMID 10438368 DOI: 10.1086/314946  0.699
1999 Casadevall A, Pirofski LA. Host-pathogen interactions: Redefining the basic concepts of virulence and pathogenicity Infection and Immunity. 67: 3703-3713. PMID 10417127 DOI: 10.1128/Iai.67.8.3703-3713.1999  0.338
1999 Monari C, Casadevall A, Retini C, Baldelli F, Bistoni F, Vecchiarelli A. Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans. Aids (London, England). 13: 653-60. PMID 10397559 DOI: 10.1097/00002030-199904160-00005  0.337
1999 Chen LC, Goldman DL, Doering TL, Pirofski La, Casadevall A. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infection and Immunity. 67: 2218-24. PMID 10225877 DOI: 10.1128/Iai.67.5.2218-2224.1999  0.583
1999 Chen LC, Casadevall A. Labeling of proteins with [35S]methionine and/or [35S]cysteine in the absence of cells. Analytical Biochemistry. 269: 179-88. PMID 10094791 DOI: 10.1006/Abio.1999.4023  0.501
1999 Teitelbaum R, Glatman-Freedman A, Chen B, Robbins JB, Unanue E, Casadevall A, Bloom BR. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proceedings of the National Academy of Sciences of the United States of America. 95: 15688-93. PMID 9861031 DOI: 10.1073/Pnas.95.26.15688  0.366
1999 Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Molecular and Cellular Biology. 19: 745-50. PMID 9858597 DOI: 10.1128/Mcb.19.1.745  0.392
1999 Goldman DL, Fries BC, Franzot SP, Montella L, Casadevall A. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proceedings of the National Academy of Sciences of the United States of America. 95: 14967-72. PMID 9843999 DOI: 10.1073/Pnas.95.25.14967  0.383
1999 Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var.grubii: Separate Varietal Status for Cryptococcus neoformans Serotype A Isolates Journal of Clinical Microbiology. 37: 838-840. DOI: 10.1128/Jcm.37.3.838-840.1999  0.3
1999 Cleare W, Cherniak R, Casadevall A. In Vitro and In Vivo Stability a Cryptococcus neoformans Glucuronoxylomannan Epitope That Elicits Protective Antibodies Infection and Immunity. 67: 3096-3107. DOI: 10.1128/Iai.67.6.3096-3107.1999  0.374
1999 Chen L, Goldman DL, Doering TL, Pirofski L, Casadevall A. Antibody Response to Cryptococcus neoformans Proteins in Rodents and Humans Infection and Immunity. 67: 2218-2224. DOI: 10.1128/iai.67.5.2218-2224.1999  0.532
1999 Nosanchuk JD, Rudolph J, Rosas AL, Casadevall A. Evidence That Cryptococcus neoformans Is Melanized in Pigeon Excreta: Implications for Pathogenesis Infection and Immunity. 67: 5477-5479. DOI: 10.1128/iai.67.10.5477-5479.1999  0.736
1999 Chen L, Casadevall A. Variants of a Cryptococcus neoformansStrain Elicit Different Inflammatory Responses in Mice Clinical Diagnostic Laboratory Immunology. 6: 266-268. DOI: 10.1128/Cdli.6.2.266-268.1999  0.536
1999 Nosanchuk JD, Cleare W, Franzot SP, Casadevall A. Amphotericin B and Fluconazole Affect Cellular Charge, Macrophage Phagocytosis, and Cellular Morphology of Cryptococcus neoformans at Subinhibitory Concentrations Antimicrobial Agents and Chemotherapy. 43: 233-239. DOI: 10.1128/Aac.43.2.233  0.388
1998 Fries BC, Casadevall A. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice Journal of Infectious Diseases. 178: 1761-1766. PMID 9815230 DOI: 10.1086/314521  0.366
1998 Rivera J, Feldmesser M, Cammer M, Casadevall A. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infection and Immunity. 66: 5027-30. PMID 9746613 DOI: 10.1128/Iai.66.10.5027-5030.1998  0.511
1998 Vecchiarelli A, Casadevall A. Antibody-mediated effects against Cryptococcus neoformans: Evidence for interdependency and collaboration between humoral and cellular immunity Research in Immunology. 149: 321-333. PMID 9720950 DOI: 10.1016/S0923-2494(98)80756-6  0.366
1998 Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrobial Agents and Chemotherapy. 42: 1437-46. PMID 9624491 DOI: 10.1128/Aac.42.6.1437  0.813
1998 Lendvai N, Casadevall A, Liang Z, Goldman DL, Mukherjee J, Zuckier L. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide. The Journal of Infectious Diseases. 177: 1647-59. PMID 9607845 DOI: 10.1086/515329  0.683
1998 Feldmesser M, Kress Y, Casadevall A. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans. The Journal of Infectious Diseases. 177: 1639-46. PMID 9607844 DOI: 10.1086/515314  0.393
1998 Murphy JW, Schafer F, Casadevall A, Adesina A. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans. Infection and Immunity. 66: 2632-9. PMID 9596727 DOI: 10.1128/Iai.66.6.2632-2639.1998  0.376
1998 Casadevall A. Antibody-mediated protection against intracellular pathogens Trends in Microbiology. 6: 102-107. PMID 9582935 DOI: 10.1016/S0966-842X(98)01208-6  0.388
1998 Yuan RR, Spira G, Oh J, Paizi M, Casadevall A, Scharff MD. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infection and Immunity. 66: 1057-62. PMID 9488395 DOI: 10.1128/Iai.66.3.1057-1062.1998  0.384
1998 Vecchiarelli A, Monari C, Retini C, Pietrella D, Palazzetti B, Pitzurra L, Casadevall A. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes. European Journal of Immunology. 28: 114-21. PMID 9485191 DOI: 10.1002/(Sici)1521-4141(199801)28:01<114::Aid-Immu114>3.0.Co;2-B  0.334
1998 Feldmesser M, Casadevall A. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection Frontiers in Bioscience : a Journal and Virtual Library. 3. PMID 9445465 DOI: 10.2741/A270  0.301
1998 Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hamdan JS, Casadevall A. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infection and Immunity. 66: 89-97. PMID 9423844 DOI: 10.1128/Iai.66.1.89-97.1998  0.565
1998 Casadevall A. Antibody-based therapies as anti-infective agents Expert Opinion On Investigational Drugs. 7: 307-321. DOI: 10.1517/13543784.7.3.307  0.372
1998 Vecchiarelli A, Retini C, Casadevall A, Monari C, Pietrella D, Kozel TR. Involvement of C3a and C5a in Interleukin-8 Secretion by Human Polymorphonuclear Cells in Response to Capsular Material of Cryptococcus neoformans Infection and Immunity. 66: 4324-4330. DOI: 10.1128/Iai.66.9.4324-4330.1998  0.348
1998 Vecchiarelli A, Retini C, Monari C, Casadevall A. Specific Antibody to Cryptococcus neoformans Alters Human Leukocyte Cytokine Synthesis and Promotes T-Cell Proliferation Infection and Immunity. 66: 1244-1247. DOI: 10.1128/Iai.66.3.1244-1247.1998  0.339
1998 Rivera J, Feldmesser M, Cammer M, Casadevall A. Organ-Dependent Variation of Capsule Thickness inCryptococcus neoformans during Experimental Murine Infection Infection and Immunity. 66: 5027-5030. DOI: 10.1128/iai.66.10.5027-5030.1998  0.448
1998 Glatman-Freedman A, Casadevall A. Serum Therapy for Tuberculosis Revisited: Reappraisal of the Role of Antibody-Mediated Immunity againstMycobacterium tuberculosis Clinical Microbiology Reviews. 11: 514-532. DOI: 10.1128/Cmr.11.3.514  0.361
1998 Cleare W, Casadevall A. The Different Binding Patterns of Two Immunoglobulin M Monoclonal Antibodies to Cryptococcus neoformans Serotype A and D Strains Correlate with Serotype Classification and Differences in Functional Assays Clinical Diagnostic Laboratory Immunology. 5: 125-129. DOI: 10.1128/Cdli.5.2.125-129.1998  0.321
1998 Casadevall A. Response from Casadevall Trends in Microbiology. 6: 136. DOI: 10.1016/S0966-842X(98)01243-8  0.34
1997 Blackstock R, Casadevall A. Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival Immunology. 92: 334-339. PMID 9486105 DOI: 10.1046/J.1365-2567.1997.00357.X  0.379
1997 Goldman DL, Casadevall A, Zuckier LS. Pharmacokinetics and biodistribution of a monoclonal antibody to Cryptococcus neoformans capsular polysaccharide antigen in a rat model of cryptococcal meningitis: implications for passive immunotherapy. Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society For Human and Animal Mycology. 35: 271-8. PMID 9292424 DOI: 10.1080/02681219780001261  0.35
1997 Rosas AL, Casadevall A. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. Fems Microbiology Letters. 153: 265-72. PMID 9271852 DOI: 10.1111/J.1574-6968.1997.Tb12584.X  0.72
1997 Mozaffarian N, Berman JW, Casadevall A. Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B. Antimicrobial Agents and Chemotherapy. 41: 1825-9. PMID 9257771 DOI: 10.1128/Aac.41.8.1825  0.778
1997 Chen LC, Pirofski LA, Casadevall A. Extracellular proteins of Cryptococcus neoformans and host antibody response. Infection and Immunity. 65: 2599-605. PMID 9199426 DOI: 10.1128/Iai.65.7.2599-2605.1997  0.584
1997 Yuan RR, Casadevall A, Oh J, Scharff MD. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proceedings of the National Academy of Sciences of the United States of America. 94: 2483-8. PMID 9122221 DOI: 10.1073/Pnas.94.6.2483  0.395
1997 Nussbaum G, Cleare W, Casadevall A, Scharff MD, Valadon P. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. The Journal of Experimental Medicine. 185: 685-94. PMID 9034147 DOI: 10.1084/Jem.185.4.685  0.353
1997 Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum cryptococcal antigen in patients with AIDS. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 23: 827-30. PMID 8909854 DOI: 10.1093/Clinids/23.4.827  0.316
1997 Chen LC, Pirofski LA, Casadevall A. Extracellular proteins of Cryptococcus neoformans and host antibody response. Infection and Immunity. 65: 2599-2605. DOI: 10.1128/iai.65.7.2599-2605.1997  0.514
1997 Feldmesser M, Casadevall A, Kress Y, Spira G, Orlofsky A. Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro. Infection and Immunity. 65: 1899-1907. DOI: 10.1128/Iai.65.5.1899-1907.1997  0.444
1997 Nosanchuk JD, Casadevall A. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infection and Immunity. 65: 1836-1841. DOI: 10.1128/Iai.65.5.1836-1841.1997  0.362
1997 Mozaffarian N, Berman JW, Casadevall A. Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B. Antimicrobial Agents and Chemotherapy. 41: 1825-1829. DOI: 10.1128/AAC.41.8.1825  0.766
1996 Feldmesser M, Mukherjee J, Casadevall A. Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro Journal of Antimicrobial Chemotherapy. 37: 617-622. PMID 9182119 DOI: 10.1093/Jac/37.3.617  0.417
1996 Casadevall A. Crisis in infectious diseases: Time for a new paradigm? Clinical Infectious Diseases. 23: 790-794. PMID 8909846 DOI: 10.1093/Clinids/23.4.790  0.336
1996 Casadevall A. Antibody-Based Therapies for Emerging Infectious Diseases Emerging Infectious Diseases. 2: 200-208. PMID 8903230 DOI: 10.3201/Eid0203.960306  0.359
1996 Pirofski LA, Casadevall A. Cryptococcus neoformans: Paradigm for the role of antibody immunity against fungi? Zentralblatt Fur Bakteriologie. 284: 475-495. PMID 8899968 DOI: 10.1016/S0934-8840(96)80001-6  0.441
1996 Spira G, Paizi M, Mazar S, Nussbaum G, Mukherjee S, Casadevall A. Generation of biologically active anti-Cryptococcus neoformans IgG, IgE and IgA isotype switch variant antibodies by acridine orange mutagenesis. Clinical and Experimental Immunology. 105: 436-42. PMID 8809131 DOI: 10.1046/J.1365-2249.1996.D01-786.X  0.378
1996 Nussbaum G, Yuan R, Casadevall A, Scharff MD. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans. The Journal of Experimental Medicine. 183: 1905-9. PMID 8666947 DOI: 10.1084/Jem.183.4.1905  0.41
1996 Mukherjee S, Feldmesser M, Casadevall A. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. The Journal of Infectious Diseases. 173: 1222-31. PMID 8627076 DOI: 10.1093/Infdis/173.5.1222  0.408
1996 Lee SC, Kress Y, Dickson DW, Casadevall A. Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody. Journal of Neuroimmunology. 62: 43-52. PMID 7499491 DOI: 10.1016/0165-5728(95)00097-L  0.42
1996 Fries BC, Chen F, Currie BP, Casadevall A. Karyotype instability in Cryptococcus neoformans infection. Journal of Clinical Microbiology. 34: 1531-1534. DOI: 10.1128/Jcm.34.6.1531-1534.1996  0.314
1996 Chen LC, Blank ES, Casadevall A. Extracellular proteinase activity of Cryptococcus neoformans. Clinical and Diagnostic Laboratory Immunology. 3: 570-574. DOI: 10.1128/cdli.3.5.570-574.1996  0.429
1996 Wang Y, Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine. Antimicrobial Agents and Chemotherapy. 40: 541-545. DOI: 10.1128/Aac.40.3.541  0.331
1995 Fan M, Chen LC, Ragan MA, Gutell RR, Warner JR, Currie BP, Casadevall A. The 5S rRNA and the rRNA intergenic spacer of the two varieties of Cryptococcus neoformans. Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society For Human and Animal Mycology. 33: 215-21. PMID 8531018 DOI: 10.1080/02681219580000451  0.531
1995 Mukherjee J, Nussbaum G, Scharff MD, Casadevall A. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. The Journal of Experimental Medicine. 181: 405-9. PMID 7807020 DOI: 10.1084/Jem.181.1.405  0.396
1995 Mozaffarian N, Berman JW, Casadevall A. Immune complexes increase nitric oxide production by interferon-gamma- stimulated murine macrophage-like J774.16 cells. Journal of Leukocyte Biology. 57: 657-62. PMID 7722422 DOI: 10.1002/Jlb.57.4.657  0.77
1995 Mukherjee J, Scharff MD, Casadevall A. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infection and Immunity. 63: 3353-9. PMID 7642262 DOI: 10.1128/Iai.63.9.3353-3359.1995  0.36
1995 Mukherjee J, Cleare W, Casadevall A. Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans Journal of Immunological Methods. 184: 139-143. PMID 7622865 DOI: 10.1016/0022-1759(95)00097-T  0.323
1995 Casadevall A, Scharff MD. Return to the past: the case for antibody-based therapies in infectious diseases. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 21: 150-61. PMID 7578724 DOI: 10.1093/Clinids/21.1.150  0.35
1995 Casadevall A. Antibody immunity andCryptococcus neoformans Canadian Journal of Botany. 73: 1180-1186. DOI: 10.1139/b95-376  0.324
1995 Goldman DL, Lee SC, Casadevall A. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infection and Immunity. 63: 3448-3453. DOI: 10.1128/Iai.63.9.3448-3453.1995  0.34
1995 Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infection and Immunity. 63: 3131-3136. DOI: 10.1128/Iai.63.8.3131-3136.1995  0.369
1995 Casadevall A. Antibody immunity and invasive fungal infections. Infection and Immunity. 63: 4211-4218. DOI: 10.1128/Iai.63.11.4211-4218.1995  0.381
1994 Mukherjee J, Zuckier LS, Scharff MD, Casadevall A. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrobial Agents and Chemotherapy. 38: 580-7. PMID 8203858 DOI: 10.1128/Aac.38.3.580  0.391
1994 Mukherjee S, Lee S, Mukherjee J, Scharff MD, Casadevall A. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infection and Immunity. 62: 1079-88. PMID 8112842 DOI: 10.1128/Iai.62.3.1079-1088.1994  0.337
Show low-probability matches.